Skip to Main Navigation
Skip to Page Content

COVID-19 is an emerging, rapidly evolving situation.

Get the latest public health information from CDC and research information from NIH.

U.S. flag

An official website of the United States government

Dot gov

The .gov means it's official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Share This:
https://ntp.niehs.nih.gov/go/2000

TDMS Study 05180-07 Pathology Tables

NTP                                        STATISTICAL ANALYSIS OF PRIMARY TUMORS                              REPORT: PEIRPT08     
LAB: Battelle Northwest                                     GALLIUM ARSENIDE                                   DATE: 03/09/99       
EXPERIMENT: 05180 TEST: 07                                                                                     TIME: 14:25:49       
TEST TYPE:  CHRONIC                             CAGES FROM 0000 TO LAST CAGE                                   PAGE:       1        
CONT: NO1-ES-25335                              ROUTE: RESPIRATORY EXPOSURE WHOLE BODY                         NTP C#: 62033B       
PATHOLOGIST: MILLER, RODNEY                                                                                    CAS: 1303-00-0000    
------------------------------------------------------------------------------------------------------------------------------------
                                                                                                                                    
                                                        2 YEAR CHRONIC MICE                                                         
                                                                                                                                    

               REASONS FOR REMOVAL:    ALL                                                                                          
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
               REMOVAL DATE RANGE:     ALL                                                                                          
                                                                                                                                    
               TREATMENT GROUPS:       INCLUDE ALL                                                                                  
NTP                                        STATISTICAL ANALYSIS OF PRIMARY TUMORS                              REPORT: PEIRPT08
LAB: Battelle Northwest                                     GALLIUM ARSENIDE                                   DATE: 03/09/99

EXPERIMENT: 05180 TEST: 07                                                                                     TIME: 14:25:49
TEST TYPE:  CHRONIC                             CAGES FROM 0000 TO LAST CAGE
CONT: NO1-ES-25335                              ROUTE: RESPIRATORY EXPOSURE WHOLE BODY                         NTP C#: 62033B
PATHOLOGIST: MILLER, RODNEY                                                                                    CAS: 1303-00-0000

Mice(B6C3F1)
-----------------------------
FOR ALL DOSES THE TUMOR RATES IN THE FOLLOWING TISSUES/ORGANS ARE
BASED ON NUMBER OF TISSUES EXAMINED.  IN OTHER TISSUES/ORGANS RATES
ARE BASED ON THE NUMBER OF ANIMALS NECROPSIED.
                                                 ---------------
                                                 Adrenal Cortex
                                                 Adrenal Medulla
                                                 Bone Marrow
                                                 Brain
                                                 Heart
                                                 Islets, Pancreatic
                                                 Kidney
                                                 Liver
                                                 Lung
                                                 Ovary
                                                 Pituitary Gland
                                                 Spleen
                                                 Testes
                                                 Thyroid Gland
                                                 Urinary Bladder
NTP                                        STATISTICAL ANALYSIS OF PRIMARY TUMORS                              REPORT: PEIRPT08   
LAB: Battelle Northwest                                     GALLIUM ARSENIDE                                   DATE: 03/09/99     
EXPERIMENT: 05180 TEST: 07                                                                                     TIME: 14:25:49     
TEST TYPE:  CHRONIC                             CAGES FROM 0000 TO LAST CAGE                                                      
CONT: NO1-ES-25335                              ROUTE: RESPIRATORY EXPOSURE WHOLE BODY                         NTP C#: 62033B     
PATHOLOGIST: MILLER, RODNEY                                                                                    CAS: 1303-00-0000  



SUMMARY OF STATISTICALLY SIGNIFICANT (P<=.05) RESULTS
IN THE ANALYSIS OF                 GALLIUM ARSENIDE
===============================================================

Male Mice
------------
Organ                                 Morphology
-----                                 ----------
Harderian Gland                        Carcinoma or Adenoma
===============================================================
Female Mice
------------
Organ                                  Morphology
-----                                  ----------
Liver                                  Hepatocellular Carcinoma
Stomach, Forestomach                   Squamous Cell Papilloma
Thyroid Gland: Follicular Cell         Carcinoma
                                       Carcinoma or Adenoma
All Organs                             Malignant Lymphoma: Histiocytic, Lymphocytic, Mixed, NOS, or Undifferentiated Cell Type
                                       Malignant and Benign Tumors
===============================================================
       Date:  03/09/99                           EXPERIMENT: 05180 TEST: 07                                            Page 1
                     Statistical Analysis of Primary Tumors in Mice(B6C3F1)        -                  GALLIUM ARSENIDE
                                         Terminal Sacrifice at 105 weeks 
|=================================================================================================================================|
|                   |                                                        |                                                    |
|                   |                              Males                     |                       Females                      |
|Dose               |     CONTROL      0.1          0.5          1.0         |CONTROL      0.1          0.5          1.0          |
|                   |                  MG/M3        MG/M3        MG/M3       |             MG/M3        MG/M3        MG/M3        |
|=================================================================================================================================|
|                                                                                                                                 |
|Bone Marrow                                                                                                                      |
|     Hemangiosarcoma                                                                                                             |
|                                                                                                                                 |
|                                                                                                                                 |
|---------------------------------------------------------------------------------------------------------------------------------|
|TUMOR RATES        |                                                        |                                                    |
|-----------        |                                                        |                                                    |
|OVERALL (a)        |     0/49 (0%)    0/50 (0%)    2/50 (4%)    1/48 (2%)   |1/50 (2%)    1/50 (2%)    0/50 (0%)    0/50 (0%)    |
|POLY-3 ADJUSTED (b)|     0.0%         0.0%         4.6%         2.2%        |2.2%         2.2%         0.0%         0.0%         |
|TERMINAL (d)       |     0/34 (0%)    0/38 (0%)    0/34 (0%)    0/34 (0%)   |1/36 (3%)    0/34 (0%)    0/31 (0%)    0/29 (0%)    |
|FIRST INCIDENCE    |     ---          ---          502          665         |735 (T)      672          ---          ---          |
|-------------------|                                                        |                                                    |
|STATISTICAL TESTS  |                                                        |                                                    |
|-------------------|                                                        |                                                    |
|LIFE TABLE         |     P=0.212      (e)          P=0.237      P=0.500     |P=0.236N     P=0.759      P=0.530N     P=0.543N     |
|POLY 3             |     P=0.216      (e)          P=0.242      P=0.507     |P=0.220N     P=0.757N     P=0.520N     P=0.513N     |
|POLY 1.5           |     P=0.212      (e)          P=0.243      P=0.505     |P=0.216N     P=0.759N     P=0.513N     P=0.507N     |
|POLY 6             |     P=0.219      (e)          P=0.242      P=0.510     |P=0.224N     P=0.755N     P=0.526N     P=0.519N     |
|LOGISTIC REGRESSION|     P=0.147      (e)          P=0.220      P=0.475     |P=0.214N     P=0.762N     (e)          (e)          |
|COCH-ARM / FISHERS |     P=0.201      (e)          P=0.253      P=0.495     |P=0.208N     P=0.753N     P=0.500N     P=0.500N     |
|=================================================================================================================================|
|                   |                                                        |                                                    |
|                   |                              Males                     |                       Females                      |
|Dose               |     CONTROL      0.1          0.5          1.0         |CONTROL      0.1          0.5          1.0          |
|                   |                  MG/M3        MG/M3        MG/M3       |             MG/M3        MG/M3        MG/M3        |
|=================================================================================================================================|
|                                                                                                                                 |
|Harderian Gland                                                                                                                  |
|     Adenoma                                                                                                                     |
|                                                                                                                                 |
|                                                                                                                                 |
|---------------------------------------------------------------------------------------------------------------------------------|
|TUMOR RATES        |     #            #            #            #           |#            #            #            #            |
|-----------        |                                                        |                                                    |
|OVERALL (a)        |     4/50 (8%)    6/50 (12%)   8/50 (16%)   8/50 (16%)  |2/50 (4%)    3/50 (6%)    2/50 (4%)    2/50 (4%)    |
|POLY-3 ADJUSTED (b)|     9.1%         12.9%        17.8%        17.3%       |4.4%         6.6%         4.9%         4.8%         |
|TERMINAL (d)       |     4/35 (11%)   3/38 (8%)    3/34 (9%)    4/34 (12%)  |1/36 (3%)    2/34 (6%)    1/31 (3%)    2/29 (7%)    |
|FIRST INCIDENCE    |     733 (T)      609          548          561         |633          659          643          735 (T)      |
|-------------------|                                                        |                                                    |
|STATISTICAL TESTS  |                                                        |                                                    |
|-------------------|                                                        |                                                    |
|LIFE TABLE         |     P=0.139      P=0.429      P=0.176      P=0.179     |P=0.569N     P=0.497      P=0.639      P=0.626      |
|POLY 3             |     P=0.164      P=0.405      P=0.189      P=0.201     |P=0.524N     P=0.504      P=0.658      P=0.668      |
|POLY 1.5           |     P=0.161      P=0.395      P=0.185      P=0.195     |P=0.506N     P=0.500      P=0.670      P=0.679      |
|POLY 6             |     P=0.167      P=0.419      P=0.197      P=0.209     |P=0.543N     P=0.506      P=0.647      P=0.655      |
|LOGISTIC REGRESSION|     P=0.147      P=0.397      P=0.178      P=0.184     |P=0.505N     P=0.500      P=0.693      P=0.680      |
|COCH-ARM / FISHERS |     P=0.149      P=0.370      P=0.178      P=0.178     |P=0.483N     P=0.500      P=0.691N     P=0.691N     |
|=================================================================================================================================|
       Date:  03/09/99                           EXPERIMENT: 05180 TEST: 07                                            Page 2
                     Statistical Analysis of Primary Tumors in Mice(B6C3F1)       -                  GALLIUM ARSENIDE
                                         Terminal Sacrifice at 105 weeks 
|=================================================================================================================================|
|                   |                                                        |                                                    |
|                   |                              Males                     |                       Females                      |
|Dose               |     CONTROL      0.1          0.5          1.0         |CONTROL      0.1          0.5          1.0          |
|                   |                  MG/M3        MG/M3        MG/M3       |             MG/M3        MG/M3        MG/M3        |
|=================================================================================================================================|
|                                                                                                                                 |
|Harderian Gland                                                                                                                  |
|     Carcinoma                                                                                                                   |
|                                                                                                                                 |
|                                                                                                                                 |
|---------------------------------------------------------------------------------------------------------------------------------|
|TUMOR RATES        |     #            #            #            #           |#            #            #            #            |
|-----------        |                                                        |                                                    |
|OVERALL (a)        |     1/50 (2%)    1/50 (2%)    3/50 (6%)    4/50 (8%)   |3/50 (6%)    1/50 (2%)    1/50 (2%)    0/50 (0%)    |
|POLY-3 ADJUSTED (b)|     2.3%         2.2%         6.9%         8.9%        |6.6%         2.2%         2.5%         0.0%         |
|TERMINAL (d)       |     0/35 (0%)    1/38 (3%)    2/34 (6%)    4/34 (12%)  |2/36 (6%)    1/34 (3%)    1/31 (3%)    0/29 (0%)    |
|FIRST INCIDENCE    |     686          733 (T)      645          733 (T)     |617          735 (T)      735 (T)      ---          |
|-------------------|                                                        |                                                    |
|STATISTICAL TESTS  |                                                        |                                                    |
|-------------------|                                                        |                                                    |
|LIFE TABLE         |     P=0.056      P=0.746N     P=0.290      P=0.173     |P=0.121N     P=0.320N     P=0.360N     P=0.155N     |
|POLY 3             |     P=0.064      P=0.752N     P=0.299      P=0.185     |P=0.105N     P=0.305N     P=0.345N     P=0.132N     |
|POLY 1.5           |     P=0.065      P=0.754N     P=0.302      P=0.185     |P=0.099N     P=0.306N     P=0.331N     P=0.126N     |
|POLY 6             |     P=0.062      P=0.749N     P=0.294      P=0.183     |P=0.110N     P=0.304N     P=0.358N     P=0.139N     |
|LOGISTIC REGRESSION|     P=0.065      P=0.757N     P=0.303      P=0.186     |P=0.102N     P=0.305N     P=0.328N     P=0.121N     |
|COCH-ARM / FISHERS |     P=0.065      P=0.753N     P=0.309      P=0.181     |P=0.093N     P=0.309N     P=0.309N     P=0.121N     |
|=================================================================================================================================|
|                   |                                                        |                                                    |
|                   |                              Males                     |                       Females                      |
|Dose               |     CONTROL      0.1          0.5          1.0         |CONTROL      0.1          0.5          1.0          |
|                   |                  MG/M3        MG/M3        MG/M3       |             MG/M3        MG/M3        MG/M3        |
|=================================================================================================================================|
|                                                                                                                                 |
|Harderian Gland                                                                                                                  |
|     Carcinoma or Adenoma                                                                                                        |
|                                                                                                                                 |
|                                                                                                                                 |
|---------------------------------------------------------------------------------------------------------------------------------|
|TUMOR RATES        |     #            #            #            #           |#            #            #            #            |
|-----------        |                                                        |                                                    |
|OVERALL (a)        |     5/50 (10%)   7/50 (14%)   10/50 (20%)  12/50 (24%) |5/50 (10%)   4/50 (8%)    3/50 (6%)    2/50 (4%)    |
|POLY-3 ADJUSTED (b)|     11.4%        15.1%        22.2%        26.0%       |11.0%        8.8%         7.3%         4.8%         |
|TERMINAL (d)       |     4/35 (11%)   4/38 (11%)   5/34 (15%)   8/34 (24%)  |3/36 (8%)    3/34 (9%)    2/31 (7%)    2/29 (7%)    |
|FIRST INCIDENCE    |     686          609          548          561         |617          659          643          735 (T)      |
|-------------------|                                                        |                                                    |
|STATISTICAL TESTS  |                                                        |                                                    |
|-------------------|                                                        |                                                    |
|LIFE TABLE         |     P=0.030 *    P=0.443      P=0.129      P=0.057     |P=0.228N     P=0.513N     P=0.441N     P=0.297N     |
|POLY 3             |     P=0.036 *    P=0.416      P=0.138      P=0.063     |P=0.189N     P=0.500N     P=0.417N     P=0.250N     |
|POLY 1.5           |     P=0.035 *    P=0.406      P=0.135      P=0.061     |P=0.173N     P=0.502N     P=0.397N     P=0.235N     |
|POLY 6             |     P=0.036 *    P=0.429      P=0.144      P=0.066     |P=0.207N     P=0.501N     P=0.437N     P=0.268N     |
|LOGISTIC REGRESSION|     P=0.033 *    P=0.408      P=0.131      P=0.060     |P=0.172N     P=0.500N     P=0.377N     P=0.227N     |
|COCH-ARM / FISHERS |     P=0.033 *    P=0.380      P=0.131      P=0.054     |P=0.154N     P=0.500N     P=0.357N     P=0.218N     |
|=================================================================================================================================|
       Date:  03/09/99                           EXPERIMENT: 05180 TEST: 07                                            Page 3
                     Statistical Analysis of Primary Tumors in Mice(B6C3F1)       -                  GALLIUM ARSENIDE
                                         Terminal Sacrifice at 105 weeks 
|=================================================================================================================================|
|                   |                                                        |                                                    |
|                   |                              Males                     |                       Females                      |
|Dose               |     CONTROL      0.1          0.5          1.0         |CONTROL      0.1          0.5          1.0          |
|                   |                  MG/M3        MG/M3        MG/M3       |             MG/M3        MG/M3        MG/M3        |
|=================================================================================================================================|
|                                                                                                                                 |
|Intestine Small: Jejunum                                                                                                         |
|     Carcinoma                                                                                                                   |
|                                                                                                                                 |
|                                                                                                                                 |
|---------------------------------------------------------------------------------------------------------------------------------|
|TUMOR RATES        |     #            #            #            #           |#            #            #            #            |
|-----------        |                                                        |                                                    |
|OVERALL (a)        |     2/50 (4%)    2/50 (4%)    0/50 (0%)    1/50 (2%)   |0/50 (0%)    0/50 (0%)    0/50 (0%)    1/50 (2%)    |
|POLY-3 ADJUSTED (b)|     4.6%         4.3%         0.0%         2.2%        |0.0%         0.0%         0.0%         2.4%         |
|TERMINAL (d)       |     2/35 (6%)    0/38 (0%)    0/34 (0%)    0/34 (0%)   |0/36 (0%)    0/34 (0%)    0/31 (0%)    0/29 (0%)    |
|FIRST INCIDENCE    |     733 (T)      481          ---          710         |---          ---          ---          707          |
|-------------------|                                                        |                                                    |
|STATISTICAL TESTS  |                                                        |                                                    |
|-------------------|                                                        |                                                    |
|LIFE TABLE         |     P=0.272N     P=0.667N     P=0.245N     P=0.497N    |P=0.171      (e)          (e)          P=0.478      |
|POLY 3             |     P=0.270N     P=0.669N     P=0.242N     P=0.491N    |P=0.178      (e)          (e)          P=0.488      |
|POLY 1.5           |     P=0.267N     P=0.676N     P=0.239N     P=0.492N    |P=0.182      (e)          (e)          P=0.493      |
|POLY 6             |     P=0.274N     P=0.659N     P=0.245N     P=0.490N    |P=0.174      (e)          (e)          P=0.482      |
|LOGISTIC REGRESSION|     P=0.275N     P=0.647      (e)          P=0.492N    |P=0.180      (e)          (e)          P=0.492      |
|COCH-ARM / FISHERS |     P=0.263N     P=0.691N     P=0.247N     P=0.500N    |P=0.186      (e)          (e)          P=0.500      |
|=================================================================================================================================|
|                   |                                                        |                                                    |
|                   |                              Males                     |                       Females                      |
|Dose               |     CONTROL      0.1          0.5          1.0         |CONTROL      0.1          0.5          1.0          |
|                   |                  MG/M3        MG/M3        MG/M3       |             MG/M3        MG/M3        MG/M3        |
|=================================================================================================================================|
|                                                                                                                                 |
|Intestine Small: Site Unspecified                                                                                                |
|     Carcinoma                                                                                                                   |
|                                                                                                                                 |
|                                                                                                                                 |
|---------------------------------------------------------------------------------------------------------------------------------|
|TUMOR RATES        |     #            #            #            #           |#            #            #            #            |
|-----------        |                                                        |                                                    |
|OVERALL (a)        |     2/50 (4%)    2/50 (4%)    0/50 (0%)    1/50 (2%)   |0/50 (0%)    0/50 (0%)    0/50 (0%)    1/50 (2%)    |
|POLY-3 ADJUSTED (b)|     4.6%         4.3%         0.0%         2.2%        |0.0%         0.0%         0.0%         2.4%         |
|TERMINAL (d)       |     2/35 (6%)    0/38 (0%)    0/34 (0%)    0/34 (0%)   |0/36 (0%)    0/34 (0%)    0/31 (0%)    0/29 (0%)    |
|FIRST INCIDENCE    |     733 (T)      481          ---          710         |---          ---          ---          707          |
|-------------------|                                                        |                                                    |
|STATISTICAL TESTS  |                                                        |                                                    |
|-------------------|                                                        |                                                    |
|LIFE TABLE         |     P=0.272N     P=0.667N     P=0.245N     P=0.497N    |P=0.171      (e)          (e)          P=0.478      |
|POLY 3             |     P=0.270N     P=0.669N     P=0.242N     P=0.491N    |P=0.178      (e)          (e)          P=0.488      |
|POLY 1.5           |     P=0.267N     P=0.676N     P=0.239N     P=0.492N    |P=0.182      (e)          (e)          P=0.493      |
|POLY 6             |     P=0.274N     P=0.659N     P=0.245N     P=0.490N    |P=0.174      (e)          (e)          P=0.482      |
|LOGISTIC REGRESSION|     P=0.275N     P=0.647      (e)          P=0.492N    |P=0.180      (e)          (e)          P=0.492      |
|COCH-ARM / FISHERS |     P=0.263N     P=0.691N     P=0.247N     P=0.500N    |P=0.186      (e)          (e)          P=0.500      |
|=================================================================================================================================|
       Date:  03/09/99                           EXPERIMENT: 05180 TEST: 07                                            Page 4
                     Statistical Analysis of Primary Tumors in Mice(B6C3F1)       -                  GALLIUM ARSENIDE
                                         Terminal Sacrifice at 105 weeks 
|=================================================================================================================================|
|                   |                                                        |                                                    |
|                   |                              Males                     |                       Females                      |
|Dose               |     CONTROL      0.1          0.5          1.0         |CONTROL      0.1          0.5          1.0          |
|                   |                  MG/M3        MG/M3        MG/M3       |             MG/M3        MG/M3        MG/M3        |
|=================================================================================================================================|
|                                                                                                                                 |
|Islets, Pancreatic                                                                                                               |
|     Adenoma                                                                                                                     |
|                                                                                                                                 |
|                                                                                                                                 |
|---------------------------------------------------------------------------------------------------------------------------------|
|TUMOR RATES        |                                                        |                                                    |
|-----------        |                                                        |                                                    |
|OVERALL (a)        |     0/50 (0%)    0/48 (0%)    3/49 (6%)    0/47 (0%)   |1/50 (2%)    0/50 (0%)    0/50 (0%)    0/48 (0%)    |
|POLY-3 ADJUSTED (b)|     0.0%         0.0%         7.1%         0.0%        |2.2%         0.0%         0.0%         0.0%         |
|TERMINAL (d)       |     0/35 (0%)    0/36 (0%)    3/34 (9%)    0/34 (0%)   |0/36 (0%)    0/34 (0%)    0/31 (0%)    0/29 (0%)    |
|FIRST INCIDENCE    |     ---          ---          733 (T)      ---         |707          ---          ---          ---          |
|-------------------|                                                        |                                                    |
|STATISTICAL TESTS  |                                                        |                                                    |
|-------------------|                                                        |                                                    |
|LIFE TABLE         |     P=0.458      (e)          P=0.116      (e)         |P=0.372N     P=0.495N     P=0.527N     P=0.522N     |
|POLY 3             |     P=0.484      (e)          P=0.113      (e)         |P=0.364N     P=0.498N     P=0.520N     P=0.518N     |
|POLY 1.5           |     P=0.478      (e)          P=0.114      (e)         |P=0.361N     P=0.500N     P=0.514N     P=0.514N     |
|POLY 6             |     P=0.488      (e)          P=0.111      (e)         |P=0.367N     P=0.498N     P=0.526N     P=0.523N     |
|LOGISTIC REGRESSION|     (e)          (e)          P=0.116      (e)         |P=0.362N     P=0.500N     P=0.515N     P=0.514N     |
|COCH-ARM / FISHERS |     P=0.458      (e)          P=0.117      (e)         |P=0.356N     P=0.500N     P=0.500N     P=0.510N     |
|=================================================================================================================================|
|                   |                                                        |                                                    |
|                   |                              Males                     |                       Females                      |
|Dose               |     CONTROL      0.1          0.5          1.0         |CONTROL      0.1          0.5          1.0          |
|                   |                  MG/M3        MG/M3        MG/M3       |             MG/M3        MG/M3        MG/M3        |
|=================================================================================================================================|
|                                                                                                                                 |
|Liver                                                                                                                            |
|     Hemangiosarcoma                                                                                                             |
|                                                                                                                                 |
|                                                                                                                                 |
|---------------------------------------------------------------------------------------------------------------------------------|
|TUMOR RATES        |                                                        |                                                    |
|-----------        |                                                        |                                                    |
|OVERALL (a)        |     1/50 (2%)    2/50 (4%)    3/50 (6%)    1/50 (2%)   |0/50 (0%)    0/50 (0%)    0/50 (0%)    0/50 (0%)    |
|POLY-3 ADJUSTED (b)|     2.3%         4.4%         7.0%         2.2%        |0.0%         0.0%         0.0%         0.0%         |
|TERMINAL (d)       |     0/35 (0%)    2/38 (5%)    2/34 (6%)    0/34 (0%)   |0/36 (0%)    0/34 (0%)    0/31 (0%)    0/29 (0%)    |
|FIRST INCIDENCE    |     570          733 (T)      692          599         |---          ---          ---          ---          |
|-------------------|                                                        |                                                    |
|STATISTICAL TESTS  |                                                        |                                                    |
|-------------------|                                                        |                                                    |
|LIFE TABLE         |     P=0.576N     P=0.524      P=0.296      P=0.750N    |(e)          (e)          (e)          (e)          |
|POLY 3             |     P=0.553N     P=0.511      P=0.294      P=0.756N    |(e)          (e)          (e)          (e)          |
|POLY 1.5           |     P=0.552N     P=0.509      P=0.300      P=0.756N    |(e)          (e)          (e)          (e)          |
|POLY 6             |     P=0.556N     P=0.514      P=0.288      P=0.756N    |(e)          (e)          (e)          (e)          |
|LOGISTIC REGRESSION|     P=0.561N     P=0.485      P=0.305      P=0.714     |(e)          (e)          (e)          (e)          |
|COCH-ARM / FISHERS |     P=0.558N     P=0.500      P=0.309      P=0.753N    |(e)          (e)          (e)          (e)          |
|=================================================================================================================================|
       Date:  03/09/99                           EXPERIMENT: 05180 TEST: 07                                            Page 5
                     Statistical Analysis of Primary Tumors in Mice(B6C3F1)       -                  GALLIUM ARSENIDE
                                         Terminal Sacrifice at 105 weeks 
|=================================================================================================================================|
|                   |                                                        |                                                    |
|                   |                              Males                     |                       Females                      |
|Dose               |     CONTROL      0.1          0.5          1.0         |CONTROL      0.1          0.5          1.0          |
|                   |                  MG/M3        MG/M3        MG/M3       |             MG/M3        MG/M3        MG/M3        |
|=================================================================================================================================|
|                                                                                                                                 |
|Liver                                                                                                                            |
|     Hepatocellular Adenoma                                                                                                      |
|                                                                                                                                 |
|                                                                                                                                 |
|---------------------------------------------------------------------------------------------------------------------------------|
|TUMOR RATES        |                                                        |                                                    |
|-----------        |                                                        |                                                    |
|OVERALL (a)        |     16/50 (32%)  18/50 (36%)  19/50 (38%)  17/50 (34%) |11/50 (22%)  10/50 (20%)  12/50 (24%)  10/50 (20%)  |
|POLY-3 ADJUSTED (b)|     35.1%        36.5%        42.4%        37.5%       |24.5%        22.0%        29.3%        23.3%        |
|TERMINAL (d)       |     13/35 (37%)  11/38 (29%)  15/34 (44%)  14/34 (41%) |11/36 (31%)  9/34 (27%)   10/31 (32%)  8/29 (28%)   |
|FIRST INCIDENCE    |     457          473          502          656         |735 (T)      715          629          505          |
|-------------------|                                                        |                                                    |
|STATISTICAL TESTS  |                                                        |                                                    |
|-------------------|                                                        |                                                    |
|LIFE TABLE         |     P=0.409      P=0.525      P=0.313      P=0.477     |P=0.347      P=0.556N     P=0.338      P=0.487      |
|POLY 3             |     P=0.412      P=0.527      P=0.306      P=0.490     |P=0.503      P=0.487N     P=0.400      P=0.547N     |
|POLY 1.5           |     P=0.452      P=0.493      P=0.323      P=0.504     |P=0.537      P=0.497N     P=0.432      P=0.526N     |
|POLY 6             |     P=0.364      P=0.568      P=0.289      P=0.474     |P=0.468      P=0.479N     P=0.375      P=0.569N     |
|LOGISTIC REGRESSION|     P=0.495      P=0.371      P=0.330      P=0.531     |P=0.427      P=0.537N     P=0.337      P=0.592N     |
|COCH-ARM / FISHERS |     P=0.492      P=0.417      P=0.338      P=0.500     |P=0.509N     P=0.500N     P=0.500      P=0.500N     |
|=================================================================================================================================|
|                   |                                                        |                                                    |
|                   |                              Males                     |                       Females                      |
|Dose               |     CONTROL      0.1          0.5          1.0         |CONTROL      0.1          0.5          1.0          |
|                   |                  MG/M3        MG/M3        MG/M3       |             MG/M3        MG/M3        MG/M3        |
|=================================================================================================================================|
|                                                                                                                                 |
|Liver                                                                                                                            |
|     Hepatocellular Carcinoma                                                                                                    |
|                                                                                                                                 |
|                                                                                                                                 |
|---------------------------------------------------------------------------------------------------------------------------------|
|TUMOR RATES        |                                                        |                                                    |
|-----------        |                                                        |                                                    |
|OVERALL (a)        |     13/50 (26%)  9/50 (18%)   12/50 (24%)  17/50 (34%) |12/50 (24%)  11/50 (22%)  4/50 (8%)    8/50 (16%)   |
|POLY-3 ADJUSTED (b)|     29.0%        19.1%        26.9%        35.3%       |26.3%        23.7%        9.7%         18.6%        |
|TERMINAL (d)       |     7/35 (20%)   6/38 (16%)   8/34 (24%)   9/34 (27%)  |8/36 (22%)   5/34 (15%)   2/31 (7%)    2/29 (7%)    |
|FIRST INCIDENCE    |     561          478          573          406         |633          659          629          628          |
|-------------------|                                                        |                                                    |
|STATISTICAL TESTS  |                                                        |                                                    |
|-------------------|                                                        |                                                    |
|LIFE TABLE         |     P=0.085      P=0.191N     P=0.532N     P=0.276     |P=0.225N     P=0.523N     P=0.065N     P=0.388N     |
|POLY 3             |     P=0.108      P=0.195N     P=0.505N     P=0.333     |P=0.140N     P=0.479N     P=0.040N*    P=0.269N     |
|POLY 1.5           |     P=0.103      P=0.204N     P=0.500N     P=0.312     |P=0.124N     P=0.493N     P=0.035N*    P=0.250N     |
|POLY 6             |     P=0.111      P=0.186N     P=0.511N     P=0.350     |P=0.159N     P=0.463N     P=0.046N*    P=0.287N     |
|LOGISTIC REGRESSION|     P=0.088      P=0.224N     P=0.508N     P=0.245     |P=0.130N     P=0.497N     P=0.040N*    P=0.266N     |
|COCH-ARM / FISHERS |     P=0.090      P=0.235N     P=0.500N     P=0.257     |P=0.105N     P=0.500N     P=0.027N*    P=0.227N     |
|=================================================================================================================================|
       Date:  03/09/99                           EXPERIMENT: 05180 TEST: 07                                            Page 6
                     Statistical Analysis of Primary Tumors in Mice(B6C3F1)       -                  GALLIUM ARSENIDE
                                         Terminal Sacrifice at 105 weeks 
|=================================================================================================================================|
|                   |                                                        |                                                    |
|                   |                              Males                     |                       Females                      |
|Dose               |     CONTROL      0.1          0.5          1.0         |CONTROL      0.1          0.5          1.0          |
|                   |                  MG/M3        MG/M3        MG/M3       |             MG/M3        MG/M3        MG/M3        |
|=================================================================================================================================|
|                                                                                                                                 |
|Liver                                                                                                                            |
|     Hepatocellular Carcinoma or Hepatocellular Adenoma                                                                          |
|                                                                                                                                 |
|                                                                                                                                 |
|---------------------------------------------------------------------------------------------------------------------------------|
|TUMOR RATES        |                                                        |                                                    |
|-----------        |                                                        |                                                    |
|OVERALL (a)        |     26/50 (52%)  23/50 (46%)  27/50 (54%)  30/50 (60%) |21/50 (42%)  19/50 (38%)  14/50 (28%)  18/50 (36%)  |
|POLY-3 ADJUSTED (b)|     55.7%        46.6%        58.0%        61.8%       |46.1%        40.8%        33.9%        41.1%        |
|TERMINAL (d)       |     17/35 (49%)  15/38 (40%)  19/34 (56%)  19/34 (56%) |17/36 (47%)  12/34 (35%)  11/31 (36%)  10/29 (35%)  |
|FIRST INCIDENCE    |     457          473          502          406         |633          659          629          505          |
|-------------------|                                                        |                                                    |
|STATISTICAL TESTS  |                                                        |                                                    |
|-------------------|                                                        |                                                    |
|LIFE TABLE         |     P=0.117      P=0.252N     P=0.455      P=0.299     |P=0.507      P=0.478N     P=0.243N     P=0.523      |
|POLY 3             |     P=0.129      P=0.244N     P=0.494      P=0.344     |P=0.357N     P=0.383N     P=0.172N     P=0.395N     |
|POLY 1.5           |     P=0.134      P=0.269N     P=0.502      P=0.332     |P=0.316N     P=0.405N     P=0.146N     P=0.371N     |
|POLY 6             |     P=0.121      P=0.221N     P=0.487      P=0.353     |P=0.401N     P=0.355N     P=0.197N     P=0.417N     |
|LOGISTIC REGRESSION|     P=0.127      P=0.365N     P=0.494      P=0.280     |P=0.401N     P=0.398N     P=0.201N     P=0.440N     |
|COCH-ARM / FISHERS |     P=0.128      P=0.345N     P=0.500      P=0.273     |P=0.268N     P=0.419N     P=0.104N     P=0.341N     |
|=================================================================================================================================|
|                   |                                                        |                                                    |
|                   |                              Males                     |                       Females                      |
|Dose               |     CONTROL      0.1          0.5          1.0         |CONTROL      0.1          0.5          1.0          |
|                   |                  MG/M3        MG/M3        MG/M3       |             MG/M3        MG/M3        MG/M3        |
|=================================================================================================================================|
|                                                                                                                                 |
|Liver                                                                                                                            |
|     Hepatocellular Carcinoma, Hepatocellular Adenoma,                                                                           |
|     or Hepatoblastoma                                                                                                           |
|                                                                                                                                 |
|---------------------------------------------------------------------------------------------------------------------------------|
|TUMOR RATES        |                                                        |                                                    |
|-----------        |                                                        |                                                    |
|OVERALL (a)        |     26/50 (52%)  23/50 (46%)  27/50 (54%)  30/50 (60%) |21/50 (42%)  19/50 (38%)  14/50 (28%)  18/50 (36%)  |
|POLY-3 ADJUSTED (b)|     55.7%        46.6%        58.0%        61.8%       |46.1%        40.8%        33.9%        41.1%        |
|TERMINAL (d)       |     17/35 (49%)  15/38 (40%)  19/34 (56%)  19/34 (56%) |17/36 (47%)  12/34 (35%)  11/31 (36%)  10/29 (35%)  |
|FIRST INCIDENCE    |     457          473          502          406         |633          659          629          505          |
|-------------------|                                                        |                                                    |
|STATISTICAL TESTS  |                                                        |                                                    |
|-------------------|                                                        |                                                    |
|LIFE TABLE         |     P=0.117      P=0.252N     P=0.455      P=0.299     |P=0.507      P=0.478N     P=0.243N     P=0.523      |
|POLY 3             |     P=0.129      P=0.244N     P=0.494      P=0.344     |P=0.357N     P=0.383N     P=0.172N     P=0.395N     |
|POLY 1.5           |     P=0.134      P=0.269N     P=0.502      P=0.332     |P=0.316N     P=0.405N     P=0.146N     P=0.371N     |
|POLY 6             |     P=0.121      P=0.221N     P=0.487      P=0.353     |P=0.401N     P=0.355N     P=0.197N     P=0.417N     |
|LOGISTIC REGRESSION|     P=0.127      P=0.365N     P=0.494      P=0.280     |P=0.401N     P=0.398N     P=0.201N     P=0.440N     |
|COCH-ARM / FISHERS |     P=0.128      P=0.345N     P=0.500      P=0.273     |P=0.268N     P=0.419N     P=0.104N     P=0.341N     |
|=================================================================================================================================|
       Date:  03/09/99                           EXPERIMENT: 05180 TEST: 07                                            Page 7
                     Statistical Analysis of Primary Tumors in Mice(B6C3F1)       -                  GALLIUM ARSENIDE
                                         Terminal Sacrifice at 105 weeks 
|=================================================================================================================================|
|                   |                                                        |                                                    |
|                   |                              Males                     |                       Females                      |
|Dose               |     CONTROL      0.1          0.5          1.0         |CONTROL      0.1          0.5          1.0          |
|                   |                  MG/M3        MG/M3        MG/M3       |             MG/M3        MG/M3        MG/M3        |
|=================================================================================================================================|
|                                                                                                                                 |
|Liver                                                                                                                            |
|     Hepatocholangiocarcinoma                                                                                                    |
|                                                                                                                                 |
|                                                                                                                                 |
|---------------------------------------------------------------------------------------------------------------------------------|
|TUMOR RATES        |                                                        |                                                    |
|-----------        |                                                        |                                                    |
|OVERALL (a)        |     0/50 (0%)    2/50 (4%)    0/50 (0%)    0/50 (0%)   |0/50 (0%)    0/50 (0%)    1/50 (2%)    2/50 (4%)    |
|POLY-3 ADJUSTED (b)|     0.0%         4.3%         0.0%         0.0%        |0.0%         0.0%         2.4%         4.7%         |
|TERMINAL (d)       |     0/35 (0%)    1/38 (3%)    0/34 (0%)    0/34 (0%)   |0/36 (0%)    0/34 (0%)    0/31 (0%)    0/29 (0%)    |
|FIRST INCIDENCE    |     ---          481          ---          ---         |---          ---          553          490          |
|-------------------|                                                        |                                                    |
|STATISTICAL TESTS  |                                                        |                                                    |
|-------------------|                                                        |                                                    |
|LIFE TABLE         |     P=0.268N     P=0.251      (e)          (e)         |P=0.054      (e)          P=0.487      P=0.219      |
|POLY 3             |     P=0.254N     P=0.251      (e)          (e)         |P=0.055      (e)          P=0.483      P=0.227      |
|POLY 1.5           |     P=0.256N     P=0.247      (e)          (e)         |P=0.057      (e)          P=0.488      P=0.232      |
|POLY 6             |     P=0.253N     P=0.255      (e)          (e)         |P=0.052      (e)          P=0.479      P=0.222      |
|LOGISTIC REGRESSION|     P=0.283N     P=0.176      (e)          (e)         |P=0.059      (e)          P=0.563      P=0.250      |
|COCH-ARM / FISHERS |     P=0.264N     P=0.247      (e)          (e)         |P=0.060      (e)          P=0.500      P=0.247      |
|=================================================================================================================================|
|                   |                                                        |                                                    |
|                   |                              Males                     |                       Females                      |
|Dose               |     CONTROL      0.1          0.5          1.0         |CONTROL      0.1          0.5          1.0          |
|                   |                  MG/M3        MG/M3        MG/M3       |             MG/M3        MG/M3        MG/M3        |
|=================================================================================================================================|
|                                                                                                                                 |
|Lung                                                                                                                             |
|     Alveolar/Bronchiolar Adenoma                                                                                                |
|                                                                                                                                 |
|                                                                                                                                 |
|---------------------------------------------------------------------------------------------------------------------------------|
|TUMOR RATES        |                                                        |                                                    |
|-----------        |                                                        |                                                    |
|OVERALL (a)        |     13/50 (26%)  10/50 (20%)  11/50 (22%)  7/50 (14%)  |6/50 (12%)   4/50 (8%)    1/50 (2%)    3/50 (6%)    |
|POLY-3 ADJUSTED (b)|     29.4%        21.6%        25.6%        15.3%       |13.3%        8.8%         2.5%         7.1%         |
|TERMINAL (d)       |     11/35 (31%)  8/38 (21%)   10/34 (29%)  5/34 (15%)  |4/36 (11%)   4/34 (12%)   1/31 (3%)    2/29 (7%)    |
|FIRST INCIDENCE    |     686          659          729          555         |617          735 (T)      735 (T)      595          |
|-------------------|                                                        |                                                    |
|STATISTICAL TESTS  |                                                        |                                                    |
|-------------------|                                                        |                                                    |
|LIFE TABLE         |     P=0.160N     P=0.244N     P=0.443N     P=0.119N    |P=0.231N     P=0.403N     P=0.089N     P=0.345N     |
|POLY 3             |     P=0.111N     P=0.271N     P=0.437N     P=0.085N    |P=0.179N     P=0.369N     P=0.075N     P=0.273N     |
|POLY 1.5           |     P=0.112N     P=0.283N     P=0.420N     P=0.089N    |P=0.168N     P=0.372N     P=0.068N     P=0.260N     |
|POLY 6             |     P=0.113N     P=0.256N     P=0.458N     P=0.081N    |P=0.191N     P=0.369N     P=0.082N     P=0.288N     |
|LOGISTIC REGRESSION|     P=0.122N     P=0.257N     P=0.460N     P=0.093N    |P=0.184N     P=0.361N     P=0.075N     P=0.258N     |
|COCH-ARM / FISHERS |     P=0.119N     P=0.318N     P=0.408N     P=0.105N    |P=0.154N     P=0.370N     P=0.056N     P=0.243N     |
|=================================================================================================================================|
       Date:  03/09/99                           EXPERIMENT: 05180 TEST: 07                                            Page 8
                     Statistical Analysis of Primary Tumors in Mice(B6C3F1)       -                  GALLIUM ARSENIDE
                                         Terminal Sacrifice at 105 weeks 
|=================================================================================================================================|
|                   |                                                        |                                                    |
|                   |                              Males                     |                       Females                      |
|Dose               |     CONTROL      0.1          0.5          1.0         |CONTROL      0.1          0.5          1.0          |
|                   |                  MG/M3        MG/M3        MG/M3       |             MG/M3        MG/M3        MG/M3        |
|=================================================================================================================================|
|                                                                                                                                 |
|Lung                                                                                                                             |
|     Alveolar/Bronchiolar Carcinoma                                                                                              |
|                                                                                                                                 |
|                                                                                                                                 |
|---------------------------------------------------------------------------------------------------------------------------------|
|TUMOR RATES        |                                                        |                                                    |
|-----------        |                                                        |                                                    |
|OVERALL (a)        |     3/50 (6%)    6/50 (12%)   6/50 (12%)   6/50 (12%)  |1/50 (2%)    0/50 (0%)    3/50 (6%)    3/50 (6%)    |
|POLY-3 ADJUSTED (b)|     6.8%         13.0%        13.6%        13.3%       |2.2%         0.0%         7.3%         6.9%         |
|TERMINAL (d)       |     3/35 (9%)    4/38 (11%)   3/34 (9%)    5/34 (15%)  |1/36 (3%)    0/34 (0%)    2/31 (7%)    1/29 (3%)    |
|FIRST INCIDENCE    |     733 (T)      705          393          699         |735 (T)      ---          659          365          |
|-------------------|                                                        |                                                    |
|STATISTICAL TESTS  |                                                        |                                                    |
|-------------------|                                                        |                                                    |
|LIFE TABLE         |     P=0.254      P=0.294      P=0.234      P=0.230     |P=0.059      P=0.511N     P=0.255      P=0.267      |
|POLY 3             |     P=0.296      P=0.267      P=0.244      P=0.255     |P=0.071      P=0.498N     P=0.273      P=0.295      |
|POLY 1.5           |     P=0.298      P=0.260      P=0.245      P=0.254     |P=0.075      P=0.500N     P=0.283      P=0.301      |
|POLY 6             |     P=0.292      P=0.276      P=0.242      P=0.256     |P=0.066      P=0.497N     P=0.265      P=0.288      |
|LOGISTIC REGRESSION|     P=0.290      P=0.274      P=0.242      P=0.249     |P=0.084      (e)          P=0.268      P=0.331      |
|COCH-ARM / FISHERS |     P=0.289      P=0.243      P=0.243      P=0.243     |P=0.078      P=0.500N     P=0.309      P=0.309      |
|=================================================================================================================================|
|                   |                                                        |                                                    |
|                   |                              Males                     |                       Females                      |
|Dose               |     CONTROL      0.1          0.5          1.0         |CONTROL      0.1          0.5          1.0          |
|                   |                  MG/M3        MG/M3        MG/M3       |             MG/M3        MG/M3        MG/M3        |
|=================================================================================================================================|
|                                                                                                                                 |
|Lung                                                                                                                             |
|     Alveolar/Bronchiolar Carcinoma or Alveolar/Bronchiolar                                                                      |
|     Adenoma                                                                                                                     |
|                                                                                                                                 |
|---------------------------------------------------------------------------------------------------------------------------------|
|TUMOR RATES        |                                                        |                                                    |
|-----------        |                                                        |                                                    |
|OVERALL (a)        |     15/50 (30%)  14/50 (28%)  16/50 (32%)  13/50 (26%) |7/50 (14%)   4/50 (8%)    4/50 (8%)    6/50 (12%)   |
|POLY-3 ADJUSTED (b)|     34.0%        30.2%        36.3%        28.3%       |15.5%        8.8%         9.8%         13.6%        |
|TERMINAL (d)       |     13/35 (37%)  11/38 (29%)  12/34 (35%)  10/34 (29%) |5/36 (14%)   4/34 (12%)   3/31 (10%)   3/29 (10%)   |
|FIRST INCIDENCE    |     686          659          393          555         |617          735 (T)      659          365          |
|-------------------|                                                        |                                                    |
|STATISTICAL TESTS  |                                                        |                                                    |
|-------------------|                                                        |                                                    |
|LIFE TABLE         |     P=0.503N     P=0.395N     P=0.458      P=0.440N    |P=0.426      P=0.294N     P=0.356N     P=0.605      |
|POLY 3             |     P=0.392N     P=0.438N     P=0.498      P=0.362N    |P=0.527      P=0.260N     P=0.322N     P=0.520N     |
|POLY 1.5           |     P=0.394N     P=0.455N     P=0.505      P=0.373N    |P=0.543      P=0.263N     P=0.301N     P=0.509N     |
|POLY 6             |     P=0.395N     P=0.415N     P=0.486      P=0.351N    |P=0.510      P=0.259N     P=0.340N     P=0.535N     |
|LOGISTIC REGRESSION|     P=0.416N     P=0.420N     P=0.466      P=0.380N    |P=0.552      P=0.253N     P=0.322N     P=0.471N     |
|COCH-ARM / FISHERS |     P=0.414N     P=0.500N     P=0.500      P=0.412N    |P=0.558      P=0.262N     P=0.262N     P=0.500N     |
|=================================================================================================================================|
       Date:  03/09/99                           EXPERIMENT: 05180 TEST: 07                                            Page 9
                     Statistical Analysis of Primary Tumors in Mice(B6C3F1)       -                  GALLIUM ARSENIDE
                                         Terminal Sacrifice at 105 weeks 
|=================================================================================================================================|
|                   |                                                        |                                                    |
|                   |                              Males                     |                       Females                      |
|Dose               |     CONTROL      0.1          0.5          1.0         |CONTROL      0.1          0.5          1.0          |
|                   |                  MG/M3        MG/M3        MG/M3       |             MG/M3        MG/M3        MG/M3        |
|=================================================================================================================================|
|                                                                                                                                 |
|Mammary Gland                                                                                                                    |
|     Carcinoma                                                                                                                   |
|                                                                                                                                 |
|                                                                                                                                 |
|---------------------------------------------------------------------------------------------------------------------------------|
|TUMOR RATES        |     #            #            #            #           |#            #            #            #            |
|-----------        |                                                        |                                                    |
|OVERALL (a)        |     0/50 (0%)    0/50 (0%)    0/50 (0%)    0/50 (0%)   |1/50 (2%)    1/50 (2%)    1/50 (2%)    2/50 (4%)    |
|POLY-3 ADJUSTED (b)|     0.0%         0.0%         0.0%         0.0%        |2.2%         2.2%         2.5%         4.7%         |
|TERMINAL (d)       |     0/35 (0%)    0/38 (0%)    0/34 (0%)    0/34 (0%)   |1/36 (3%)    0/34 (0%)    1/31 (3%)    1/29 (3%)    |
|FIRST INCIDENCE    |     ---          ---          ---          ---         |735 (T)      715          735 (T)      646          |
|-------------------|                                                        |                                                    |
|STATISTICAL TESTS  |                                                        |                                                    |
|-------------------|                                                        |                                                    |
|LIFE TABLE         |     (e)          (e)          (e)          (e)         |P=0.286      P=0.757      P=0.728      P=0.447      |
|POLY 3             |     (e)          (e)          (e)          (e)         |P=0.319      P=0.758N     P=0.738      P=0.481      |
|POLY 1.5           |     (e)          (e)          (e)          (e)         |P=0.330      P=0.760N     P=0.746      P=0.489      |
|POLY 6             |     (e)          (e)          (e)          (e)         |P=0.309      P=0.756N     P=0.731      P=0.472      |
|LOGISTIC REGRESSION|     (e)          (e)          (e)          (e)         |P=0.319      P=0.760N     P=0.728      P=0.488      |
|COCH-ARM / FISHERS |     (e)          (e)          (e)          (e)         |P=0.344      P=0.753N     P=0.753N     P=0.500      |
|=================================================================================================================================|
|                   |                                                        |                                                    |
|                   |                              Males                     |                       Females                      |
|Dose               |     CONTROL      0.1          0.5          1.0         |CONTROL      0.1          0.5          1.0          |
|                   |                  MG/M3        MG/M3        MG/M3       |             MG/M3        MG/M3        MG/M3        |
|=================================================================================================================================|
|                                                                                                                                 |
|Mesentery                                                                                                                        |
|     Hemangiosarcoma                                                                                                             |
|                                                                                                                                 |
|                                                                                                                                 |
|---------------------------------------------------------------------------------------------------------------------------------|
|TUMOR RATES        |     #            #            #            #           |#            #            #            #            |
|-----------        |                                                        |                                                    |
|OVERALL (a)        |     2/50 (4%)    0/50 (0%)    0/50 (0%)    0/50 (0%)   |0/50 (0%)    0/50 (0%)    1/50 (2%)    0/50 (0%)    |
|POLY-3 ADJUSTED (b)|     4.5%         0.0%         0.0%         0.0%        |0.0%         0.0%         2.4%         0.0%         |
|TERMINAL (d)       |     1/35 (3%)    0/38 (0%)    0/34 (0%)    0/34 (0%)   |0/36 (0%)    0/34 (0%)    0/31 (0%)    0/29 (0%)    |
|FIRST INCIDENCE    |     570          ---          ---          ---         |---          ---          629          ---          |
|-------------------|                                                        |                                                    |
|STATISTICAL TESTS  |                                                        |                                                    |
|-------------------|                                                        |                                                    |
|LIFE TABLE         |     P=0.166N     P=0.226N     P=0.243N     P=0.241N    |P=0.629      (e)          P=0.471      (e)          |
|POLY 3             |     P=0.167N     P=0.230N     P=0.245N     P=0.234N    |P=0.626      (e)          P=0.482      (e)          |
|POLY 1.5           |     P=0.165N     P=0.231N     P=0.241N     P=0.234N    |P=0.637      (e)          P=0.488      (e)          |
|POLY 6             |     P=0.169N     P=0.228N     P=0.249N     P=0.236N    |P=0.613      (e)          P=0.478      (e)          |
|LOGISTIC REGRESSION|     P=0.164N     P=0.257N     P=0.238N     P=0.253N    |P=0.659      (e)          P=0.528      (e)          |
|COCH-ARM / FISHERS |     P=0.160N     P=0.247N     P=0.247N     P=0.247N    |P=0.649      (e)          P=0.500      (e)          |
|=================================================================================================================================|
       Date:  03/09/99                           EXPERIMENT: 05180 TEST: 07                                            Page 10
                     Statistical Analysis of Primary Tumors in Mice(B6C3F1)       -                  GALLIUM ARSENIDE
                                         Terminal Sacrifice at 105 weeks 
|=================================================================================================================================|
|                   |                                                        |                                                    |
|                   |                              Males                     |                       Females                      |
|Dose               |     CONTROL      0.1          0.5          1.0         |CONTROL      0.1          0.5          1.0          |
|                   |                  MG/M3        MG/M3        MG/M3       |             MG/M3        MG/M3        MG/M3        |
|=================================================================================================================================|
|                                                                                                                                 |
|Ovary                                                                                                                            |
|     Cystadenoma                                                                                                                 |
|                                                                                                                                 |
|                                                                                                                                 |
|---------------------------------------------------------------------------------------------------------------------------------|
|TUMOR RATES        |                                                        |                                                    |
|-----------        |                                                        |                                                    |
|OVERALL (a)        |                                                        |2/49 (4%)    1/50 (2%)    1/50 (2%)    3/46 (7%)    |
|POLY-3 ADJUSTED (b)|                                                        |4.4%         2.2%         2.5%         7.6%         |
|TERMINAL (d)       |                                                        |1/36 (3%)    1/34 (3%)    1/31 (3%)    1/28 (4%)    |
|FIRST INCIDENCE    |                                                        |639          735 (T)      735 (T)      505          |
|-------------------|                                                        |                                                    |
|STATISTICAL TESTS  |                                                        |                                                    |
|-------------------|                                                        |                                                    |
|LIFE TABLE         |                                                        |P=0.233      P=0.506N     P=0.551N     P=0.435      |
|POLY 3             |                                                        |P=0.245      P=0.499N     P=0.537N     P=0.442      |
|POLY 1.5           |                                                        |P=0.255      P=0.499N     P=0.523N     P=0.452      |
|POLY 6             |                                                        |P=0.236      P=0.499N     P=0.549N     P=0.432      |
|LOGISTIC REGRESSION|                                                        |P=0.292      P=0.493N     P=0.517N     P=0.614      |
|COCH-ARM / FISHERS |                                                        |P=0.269      P=0.492N     P=0.492N     P=0.470      |
|=================================================================================================================================|
|                   |                                                        |                                                    |
|                   |                              Males                     |                       Females                      |
|Dose               |     CONTROL      0.1          0.5          1.0         |CONTROL      0.1          0.5          1.0          |
|                   |                  MG/M3        MG/M3        MG/M3       |             MG/M3        MG/M3        MG/M3        |
|=================================================================================================================================|
|                                                                                                                                 |
|Pituitary Gland: Pars Distalis or Unspecified Site                                                                               |
|     Adenoma                                                                                                                     |
|                                                                                                                                 |
|                                                                                                                                 |
|---------------------------------------------------------------------------------------------------------------------------------|
|TUMOR RATES        |                                                        |                                                    |
|-----------        |                                                        |                                                    |
|OVERALL (a)        |     0/48 (0%)    0/48 (0%)    0/47 (0%)    0/47 (0%)   |3/46 (7%)    7/48 (15%)   5/50 (10%)   7/47 (15%)   |
|POLY-3 ADJUSTED (b)|     0.0%         0.0%         0.0%         0.0%        |7.2%         16.1%        12.1%        17.7%        |
|TERMINAL (d)       |     0/34 (0%)    0/36 (0%)    0/33 (0%)    0/34 (0%)   |1/33 (3%)    6/34 (18%)   3/31 (10%)   6/29 (21%)   |
|FIRST INCIDENCE    |     ---          ---          ---          ---         |729          701          483          646          |
|-------------------|                                                        |                                                    |
|STATISTICAL TESTS  |                                                        |                                                    |
|-------------------|                                                        |                                                    |
|LIFE TABLE         |     (e)          (e)          (e)          (e)         |P=0.170      P=0.167      P=0.310      P=0.109      |
|POLY 3             |     (e)          (e)          (e)          (e)         |P=0.204      P=0.173      P=0.350      P=0.133      |
|POLY 1.5           |     (e)          (e)          (e)          (e)         |P=0.224      P=0.170      P=0.364      P=0.144      |
|POLY 6             |     (e)          (e)          (e)          (e)         |P=0.186      P=0.178      P=0.339      P=0.124      |
|LOGISTIC REGRESSION|     (e)          (e)          (e)          (e)         |P=0.198      P=0.177      P=0.371      P=0.119      |
|COCH-ARM / FISHERS |     (e)          (e)          (e)          (e)         |P=0.261      P=0.176      P=0.405      P=0.167      |
|=================================================================================================================================|
       Date:  03/09/99                           EXPERIMENT: 05180 TEST: 07                                            Page 11
                     Statistical Analysis of Primary Tumors in Mice(B6C3F1)       -                  GALLIUM ARSENIDE
                                         Terminal Sacrifice at 105 weeks 
|=================================================================================================================================|
|                   |                                                        |                                                    |
|                   |                              Males                     |                       Females                      |
|Dose               |     CONTROL      0.1          0.5          1.0         |CONTROL      0.1          0.5          1.0          |
|                   |                  MG/M3        MG/M3        MG/M3       |             MG/M3        MG/M3        MG/M3        |
|=================================================================================================================================|
|                                                                                                                                 |
|Pituitary Gland: Pars Distalis or Unspecified Site                                                                               |
|     Carcinoma or Adenoma                                                                                                        |
|                                                                                                                                 |
|                                                                                                                                 |
|---------------------------------------------------------------------------------------------------------------------------------|
|TUMOR RATES        |                                                        |                                                    |
|-----------        |                                                        |                                                    |
|OVERALL (a)        |     0/48 (0%)    0/48 (0%)    0/47 (0%)    0/47 (0%)   |3/46 (7%)    7/48 (15%)   6/50 (12%)   7/47 (15%)   |
|POLY-3 ADJUSTED (b)|     0.0%         0.0%         0.0%         0.0%        |7.2%         16.1%        14.5%        17.7%        |
|TERMINAL (d)       |     0/34 (0%)    0/36 (0%)    0/33 (0%)    0/34 (0%)   |1/33 (3%)    6/34 (18%)   4/31 (13%)   6/29 (21%)   |
|FIRST INCIDENCE    |     ---          ---          ---          ---         |729          701          483          646          |
|-------------------|                                                        |                                                    |
|STATISTICAL TESTS  |                                                        |                                                    |
|-------------------|                                                        |                                                    |
|LIFE TABLE         |     (e)          (e)          (e)          (e)         |P=0.158      P=0.167      P=0.205      P=0.109      |
|POLY 3             |     (e)          (e)          (e)          (e)         |P=0.189      P=0.173      P=0.235      P=0.133      |
|POLY 1.5           |     (e)          (e)          (e)          (e)         |P=0.210      P=0.170      P=0.249      P=0.144      |
|POLY 6             |     (e)          (e)          (e)          (e)         |P=0.171      P=0.178      P=0.225      P=0.124      |
|LOGISTIC REGRESSION|     (e)          (e)          (e)          (e)         |P=0.183      P=0.177      P=0.247      P=0.119      |
|COCH-ARM / FISHERS |     (e)          (e)          (e)          (e)         |P=0.247      P=0.176      P=0.287      P=0.167      |
|=================================================================================================================================|
|                   |                                                        |                                                    |
|                   |                              Males                     |                       Females                      |
|Dose               |     CONTROL      0.1          0.5          1.0         |CONTROL      0.1          0.5          1.0          |
|                   |                  MG/M3        MG/M3        MG/M3       |             MG/M3        MG/M3        MG/M3        |
|=================================================================================================================================|
|                                                                                                                                 |
|Pituitary Gland: Pars Intermedia                                                                                                 |
|     Adenoma                                                                                                                     |
|                                                                                                                                 |
|                                                                                                                                 |
|---------------------------------------------------------------------------------------------------------------------------------|
|TUMOR RATES        |                                                        |                                                    |
|-----------        |                                                        |                                                    |
|OVERALL (a)        |     0/48 (0%)    0/48 (0%)    0/47 (0%)    0/47 (0%)   |0/46 (0%)    0/48 (0%)    2/50 (4%)    0/47 (0%)    |
|POLY-3 ADJUSTED (b)|     0.0%         0.0%         0.0%         0.0%        |0.0%         0.0%         4.9%         0.0%         |
|TERMINAL (d)       |     0/34 (0%)    0/36 (0%)    0/33 (0%)    0/34 (0%)   |0/33 (0%)    0/34 (0%)    1/31 (3%)    0/29 (0%)    |
|FIRST INCIDENCE    |     ---          ---          ---          ---         |---          ---          659          ---          |
|-------------------|                                                        |                                                    |
|STATISTICAL TESTS  |                                                        |                                                    |
|-------------------|                                                        |                                                    |
|LIFE TABLE         |     (e)          (e)          (e)          (e)         |P=0.504      (e)          P=0.216      (e)          |
|POLY 3             |     (e)          (e)          (e)          (e)         |P=0.501      (e)          P=0.232      (e)          |
|POLY 1.5           |     (e)          (e)          (e)          (e)         |P=0.518      (e)          P=0.239      (e)          |
|POLY 6             |     (e)          (e)          (e)          (e)         |P=0.484      (e)          P=0.227      (e)          |
|LOGISTIC REGRESSION|     (e)          (e)          (e)          (e)         |P=0.533      (e)          P=0.243      (e)          |
|COCH-ARM / FISHERS |     (e)          (e)          (e)          (e)         |P=0.539      (e)          P=0.269      (e)          |
|=================================================================================================================================|
       Date:  03/09/99                           EXPERIMENT: 05180 TEST: 07                                            Page 12
                     Statistical Analysis of Primary Tumors in Mice(B6C3F1)       -                  GALLIUM ARSENIDE
                                         Terminal Sacrifice at 105 weeks 
|=================================================================================================================================|
|                   |                                                        |                                                    |
|                   |                              Males                     |                       Females                      |
|Dose               |     CONTROL      0.1          0.5          1.0         |CONTROL      0.1          0.5          1.0          |
|                   |                  MG/M3        MG/M3        MG/M3       |             MG/M3        MG/M3        MG/M3        |
|=================================================================================================================================|
|                                                                                                                                 |
|Pituitary Gland: Pars Intermedia                                                                                                 |
|     Carcinoma                                                                                                                   |
|                                                                                                                                 |
|                                                                                                                                 |
|---------------------------------------------------------------------------------------------------------------------------------|
|TUMOR RATES        |                                                        |                                                    |
|-----------        |                                                        |                                                    |
|OVERALL (a)        |     0/48 (0%)    0/48 (0%)    0/47 (0%)    0/47 (0%)   |0/46 (0%)    0/48 (0%)    2/50 (4%)    0/47 (0%)    |
|POLY-3 ADJUSTED (b)|     0.0%         0.0%         0.0%         0.0%        |0.0%         0.0%         4.8%         0.0%         |
|TERMINAL (d)       |     0/34 (0%)    0/36 (0%)    0/33 (0%)    0/34 (0%)   |0/33 (0%)    0/34 (0%)    0/31 (0%)    0/29 (0%)    |
|FIRST INCIDENCE    |     ---          ---          ---          ---         |---          ---          365          ---          |
|-------------------|                                                        |                                                    |
|STATISTICAL TESTS  |                                                        |                                                    |
|-------------------|                                                        |                                                    |
|LIFE TABLE         |     (e)          (e)          (e)          (e)         |P=0.524      (e)          P=0.222      (e)          |
|POLY 3             |     (e)          (e)          (e)          (e)         |P=0.498      (e)          P=0.237      (e)          |
|POLY 1.5           |     (e)          (e)          (e)          (e)         |P=0.516      (e)          P=0.242      (e)          |
|POLY 6             |     (e)          (e)          (e)          (e)         |P=0.480      (e)          P=0.234      (e)          |
|LOGISTIC REGRESSION|     (e)          (e)          (e)          (e)         |P=0.569      (e)          P=0.461      (e)          |
|COCH-ARM / FISHERS |     (e)          (e)          (e)          (e)         |P=0.539      (e)          P=0.269      (e)          |
|=================================================================================================================================|
|                   |                                                        |                                                    |
|                   |                              Males                     |                       Females                      |
|Dose               |     CONTROL      0.1          0.5          1.0         |CONTROL      0.1          0.5          1.0          |
|                   |                  MG/M3        MG/M3        MG/M3       |             MG/M3        MG/M3        MG/M3        |
|=================================================================================================================================|
|                                                                                                                                 |
|Pituitary Gland: Pars Intermedia                                                                                                 |
|     Carcinoma or Adenoma                                                                                                        |
|                                                                                                                                 |
|                                                                                                                                 |
|---------------------------------------------------------------------------------------------------------------------------------|
|TUMOR RATES        |                                                        |                                                    |
|-----------        |                                                        |                                                    |
|OVERALL (a)        |     0/48 (0%)    0/48 (0%)    0/47 (0%)    0/47 (0%)   |0/46 (0%)    0/48 (0%)    4/50 (8%)    0/47 (0%)    |
|POLY-3 ADJUSTED (b)|     0.0%         0.0%         0.0%         0.0%        |0.0%         0.0%         9.5%         0.0%         |
|TERMINAL (d)       |     0/34 (0%)    0/36 (0%)    0/33 (0%)    0/34 (0%)   |0/33 (0%)    0/34 (0%)    1/31 (3%)    0/29 (0%)    |
|FIRST INCIDENCE    |     ---          ---          ---          ---         |---          ---          365          ---          |
|-------------------|                                                        |                                                    |
|STATISTICAL TESTS  |                                                        |                                                    |
|-------------------|                                                        |                                                    |
|LIFE TABLE         |     (e)          (e)          (e)          (e)         |P=0.394      (e)          P=0.055      (e)          |
|POLY 3             |     (e)          (e)          (e)          (e)         |P=0.370      (e)          P=0.061      (e)          |
|POLY 1.5           |     (e)          (e)          (e)          (e)         |P=0.394      (e)          P=0.063      (e)          |
|POLY 6             |     (e)          (e)          (e)          (e)         |P=0.346      (e)          P=0.059      (e)          |
|LOGISTIC REGRESSION|     (e)          (e)          (e)          (e)         |P=0.467      (e)          P=0.116      (e)          |
|COCH-ARM / FISHERS |     (e)          (e)          (e)          (e)         |P=0.427      (e)          P=0.069      (e)          |
|=================================================================================================================================|
       Date:  03/09/99                           EXPERIMENT: 05180 TEST: 07                                            Page 13
                     Statistical Analysis of Primary Tumors in Mice(B6C3F1)       -                  GALLIUM ARSENIDE
                                         Terminal Sacrifice at 105 weeks 
|=================================================================================================================================|
|                   |                                                        |                                                    |
|                   |                              Males                     |                       Females                      |
|Dose               |     CONTROL      0.1          0.5          1.0         |CONTROL      0.1          0.5          1.0          |
|                   |                  MG/M3        MG/M3        MG/M3       |             MG/M3        MG/M3        MG/M3        |
|=================================================================================================================================|
|                                                                                                                                 |
|Skin                                                                                                                             |
|     Sarcoma                                                                                                                     |
|                                                                                                                                 |
|                                                                                                                                 |
|---------------------------------------------------------------------------------------------------------------------------------|
|TUMOR RATES        |     #            #            #            #           |#            #            #            #            |
|-----------        |                                                        |                                                    |
|OVERALL (a)        |     0/50 (0%)    0/50 (0%)    0/50 (0%)    0/50 (0%)   |4/50 (8%)    4/50 (8%)    2/50 (4%)    4/50 (8%)    |
|POLY-3 ADJUSTED (b)|     0.0%         0.0%         0.0%         0.0%        |8.7%         8.8%         4.8%         9.2%         |
|TERMINAL (d)       |     0/35 (0%)    0/38 (0%)    0/34 (0%)    0/34 (0%)   |0/36 (0%)    4/34 (12%)   0/31 (0%)    0/29 (0%)    |
|FIRST INCIDENCE    |     ---          ---          ---          ---         |533          735 (T)      365          412          |
|-------------------|                                                        |                                                    |
|STATISTICAL TESTS  |                                                        |                                                    |
|-------------------|                                                        |                                                    |
|LIFE TABLE         |     (e)          (e)          (e)          (e)         |P=0.540      P=0.627      P=0.396N     P=0.589      |
|POLY 3             |     (e)          (e)          (e)          (e)         |P=0.550N     P=0.636      P=0.385N     P=0.614      |
|POLY 1.5           |     (e)          (e)          (e)          (e)         |P=0.534N     P=0.637      P=0.368N     P=0.627      |
|POLY 6             |     (e)          (e)          (e)          (e)         |P=0.566N     P=0.631      P=0.404N     P=0.600      |
|LOGISTIC REGRESSION|     (e)          (e)          (e)          (e)         |P=0.484N     P=0.643N     P=0.259N     P=0.602N     |
|COCH-ARM / FISHERS |     (e)          (e)          (e)          (e)         |P=0.514N     P=0.643N     P=0.339N     P=0.643N     |
|=================================================================================================================================|
|                   |                                                        |                                                    |
|                   |                              Males                     |                       Females                      |
|Dose               |     CONTROL      0.1          0.5          1.0         |CONTROL      0.1          0.5          1.0          |
|                   |                  MG/M3        MG/M3        MG/M3       |             MG/M3        MG/M3        MG/M3        |
|=================================================================================================================================|
|                                                                                                                                 |
|Spleen                                                                                                                           |
|     Hemangiosarcoma                                                                                                             |
|                                                                                                                                 |
|                                                                                                                                 |
|---------------------------------------------------------------------------------------------------------------------------------|
|TUMOR RATES        |                                                        |                                                    |
|-----------        |                                                        |                                                    |
|OVERALL (a)        |     2/50 (4%)    0/50 (0%)    2/49 (4%)    1/47 (2%)   |0/50 (0%)    2/50 (4%)    2/50 (4%)    0/49 (0%)    |
|POLY-3 ADJUSTED (b)|     4.5%         0.0%         4.6%         2.3%        |0.0%         4.4%         4.9%         0.0%         |
|TERMINAL (d)       |     0/35 (0%)    0/38 (0%)    0/34 (0%)    0/34 (0%)   |0/36 (0%)    1/34 (3%)    2/31 (7%)    0/29 (0%)    |
|FIRST INCIDENCE    |     570          ---          502          665         |---          672          735 (T)      ---          |
|-------------------|                                                        |                                                    |
|STATISTICAL TESTS  |                                                        |                                                    |
|-------------------|                                                        |                                                    |
|LIFE TABLE         |     P=0.605      P=0.230N     P=0.684      P=0.500N    |P=0.482N     P=0.239      P=0.206      (e)          |
|POLY 3             |     P=0.601      P=0.231N     P=0.683      P=0.508N    |P=0.458N     P=0.241      P=0.216      (e)          |
|POLY 1.5           |     P=0.599      P=0.232N     P=0.686      P=0.510N    |P=0.446N     P=0.238      P=0.223      (e)          |
|POLY 6             |     P=0.600      P=0.230N     P=0.679      P=0.507N    |P=0.470N     P=0.243      P=0.209      (e)          |
|LOGISTIC REGRESSION|     P=0.544      P=0.269N     P=0.678      P=0.584N    |P=0.459N     P=0.238      P=0.206      (e)          |
|COCH-ARM / FISHERS |     P=0.592      P=0.247N     P=0.684      P=0.523N    |P=0.430N     P=0.247      P=0.247      (e)          |
|=================================================================================================================================|
       Date:  03/09/99                           EXPERIMENT: 05180 TEST: 07                                            Page 14
                     Statistical Analysis of Primary Tumors in Mice(B6C3F1)       -                  GALLIUM ARSENIDE
                                         Terminal Sacrifice at 105 weeks 
|=================================================================================================================================|
|                   |                                                        |                                                    |
|                   |                              Males                     |                       Females                      |
|Dose               |     CONTROL      0.1          0.5          1.0         |CONTROL      0.1          0.5          1.0          |
|                   |                  MG/M3        MG/M3        MG/M3       |             MG/M3        MG/M3        MG/M3        |
|=================================================================================================================================|
|                                                                                                                                 |
|Stomach, Forestomach                                                                                                             |
|     Squamous Cell Papilloma                                                                                                     |
|                                                                                                                                 |
|                                                                                                                                 |
|---------------------------------------------------------------------------------------------------------------------------------|
|TUMOR RATES        |     #            #            #            #           |#            #            #            #            |
|-----------        |                                                        |                                                    |
|OVERALL (a)        |     1/50 (2%)    0/50 (0%)    0/50 (0%)    1/50 (2%)   |0/50 (0%)    0/50 (0%)    0/50 (0%)    3/50 (6%)    |
|POLY-3 ADJUSTED (b)|     2.3%         0.0%         0.0%         2.2%        |0.0%         0.0%         0.0%         7.1%         |
|TERMINAL (d)       |     1/35 (3%)    0/38 (0%)    0/34 (0%)    1/34 (3%)   |0/36 (0%)    0/34 (0%)    0/31 (0%)    3/29 (10%)   |
|FIRST INCIDENCE    |     733 (T)      ---          ---          733 (T)     |---          ---          ---          735 (T)      |
|-------------------|                                                        |                                                    |
|STATISTICAL TESTS  |                                                        |                                                    |
|-------------------|                                                        |                                                    |
|LIFE TABLE         |     P=0.520      P=0.484N     P=0.506N     P=0.755     |P=0.007 **   (e)          (e)          P=0.085      |
|POLY 3             |     P=0.530      P=0.491N     P=0.504N     P=0.755N    |P=0.009 **   (e)          (e)          P=0.108      |
|POLY 1.5           |     P=0.532      P=0.493N     P=0.502N     P=0.755N    |P=0.009 **   (e)          (e)          P=0.112      |
|POLY 6             |     P=0.526      P=0.488N     P=0.507N     P=0.755N    |P=0.008 **   (e)          (e)          P=0.102      |
|LOGISTIC REGRESSION|     P=0.520      (e)          (e)          P=0.755     |(e)          (e)          (e)          P=0.085      |
|COCH-ARM / FISHERS |     P=0.536      P=0.500N     P=0.500N     P=0.753N    |P=0.011 *    (e)          (e)          P=0.121      |
|=================================================================================================================================|
|                   |                                                        |                                                    |
|                   |                              Males                     |                       Females                      |
|Dose               |     CONTROL      0.1          0.5          1.0         |CONTROL      0.1          0.5          1.0          |
|                   |                  MG/M3        MG/M3        MG/M3       |             MG/M3        MG/M3        MG/M3        |
|=================================================================================================================================|
|                                                                                                                                 |
|Testes                                                                                                                           |
|     Adenoma                                                                                                                     |
|                                                                                                                                 |
|                                                                                                                                 |
|---------------------------------------------------------------------------------------------------------------------------------|
|TUMOR RATES        |                                                        |                                                    |
|-----------        |                                                        |                                                    |
|OVERALL (a)        |     0/50 (0%)    0/50 (0%)    2/50 (4%)    0/50 (0%)   |                                                    |
|POLY-3 ADJUSTED (b)|     0.0%         0.0%         4.7%         0.0%        |                                                    |
|TERMINAL (d)       |     0/35 (0%)    0/38 (0%)    2/34 (6%)    0/34 (0%)   |                                                    |
|FIRST INCIDENCE    |     ---          ---          733 (T)      ---         |                                                    |
|-------------------|                                                        |                                                    |
|STATISTICAL TESTS  |                                                        |                                                    |
|-------------------|                                                        |                                                    |
|LIFE TABLE         |     P=0.520      (e)          P=0.232      (e)         |                                                    |
|POLY 3             |     P=0.544      (e)          P=0.232      (e)         |                                                    |
|POLY 1.5           |     P=0.544      (e)          P=0.235      (e)         |                                                    |
|POLY 6             |     P=0.542      (e)          P=0.229      (e)         |                                                    |
|LOGISTIC REGRESSION|     (e)          (e)          P=0.232      (e)         |                                                    |
|COCH-ARM / FISHERS |     P=0.536      (e)          P=0.247      (e)         |                                                    |
|=================================================================================================================================|
       Date:  03/09/99                           EXPERIMENT: 05180 TEST: 07                                            Page 15
                     Statistical Analysis of Primary Tumors in Mice(B6C3F1)       -                  GALLIUM ARSENIDE
                                         Terminal Sacrifice at 105 weeks 
|=================================================================================================================================|
|                   |                                                        |                                                    |
|                   |                              Males                     |                       Females                      |
|Dose               |     CONTROL      0.1          0.5          1.0         |CONTROL      0.1          0.5          1.0          |
|                   |                  MG/M3        MG/M3        MG/M3       |             MG/M3        MG/M3        MG/M3        |
|=================================================================================================================================|
|                                                                                                                                 |
|Thyroid Gland: Follicular Cell                                                                                                   |
|     Adenoma                                                                                                                     |
|                                                                                                                                 |
|                                                                                                                                 |
|---------------------------------------------------------------------------------------------------------------------------------|
|TUMOR RATES        |                                                        |                                                    |
|-----------        |                                                        |                                                    |
|OVERALL (a)        |     1/50 (2%)    1/50 (2%)    0/50 (0%)    0/48 (0%)   |1/50 (2%)    0/50 (0%)    0/50 (0%)    2/49 (4%)    |
|POLY-3 ADJUSTED (b)|     2.3%         2.2%         0.0%         0.0%        |2.2%         0.0%         0.0%         4.9%         |
|TERMINAL (d)       |     1/35 (3%)    1/38 (3%)    0/34 (0%)    0/34 (0%)   |1/36 (3%)    0/34 (0%)    0/31 (0%)    2/28 (7%)    |
|FIRST INCIDENCE    |     733 (T)      733 (T)      ---          ---         |735 (T)      ---          ---          735 (T)      |
|-------------------|                                                        |                                                    |
|STATISTICAL TESTS  |                                                        |                                                    |
|-------------------|                                                        |                                                    |
|LIFE TABLE         |     P=0.219N     P=0.743N     P=0.506N     P=0.506N    |P=0.159      P=0.511N     P=0.530N     P=0.412      |
|POLY 3             |     P=0.216N     P=0.751N     P=0.504N     P=0.498N    |P=0.188      P=0.498N     P=0.520N     P=0.470      |
|POLY 1.5           |     P=0.215N     P=0.753N     P=0.502N     P=0.500N    |P=0.195      P=0.500N     P=0.513N     P=0.480      |
|POLY 6             |     P=0.217N     P=0.747N     P=0.507N     P=0.497N    |P=0.182      P=0.497N     P=0.526N     P=0.458      |
|LOGISTIC REGRESSION|     P=0.219N     P=0.743N     (e)          (e)         |P=0.159      (e)          (e)          P=0.412      |
|COCH-ARM / FISHERS |     P=0.213N     P=0.753N     P=0.500N     P=0.510N    |P=0.204      P=0.500N     P=0.500N     P=0.492      |
|=================================================================================================================================|
|                   |                                                        |                                                    |
|                   |                              Males                     |                       Females                      |
|Dose               |     CONTROL      0.1          0.5          1.0         |CONTROL      0.1          0.5          1.0          |
|                   |                  MG/M3        MG/M3        MG/M3       |             MG/M3        MG/M3        MG/M3        |
|=================================================================================================================================|
|                                                                                                                                 |
|Thyroid Gland: Follicular Cell                                                                                                   |
|     Carcinoma                                                                                                                   |
|                                                                                                                                 |
|                                                                                                                                 |
|---------------------------------------------------------------------------------------------------------------------------------|
|TUMOR RATES        |                                                        |                                                    |
|-----------        |                                                        |                                                    |
|OVERALL (a)        |     1/50 (2%)    0/50 (0%)    0/50 (0%)    0/48 (0%)   |0/50 (0%)    0/50 (0%)    0/50 (0%)    2/49 (4%)    |
|POLY-3 ADJUSTED (b)|     2.3%         0.0%         0.0%         0.0%        |0.0%         0.0%         0.0%         4.8%         |
|TERMINAL (d)       |     1/35 (3%)    0/38 (0%)    0/34 (0%)    0/34 (0%)   |0/36 (0%)    0/34 (0%)    0/31 (0%)    0/28 (0%)    |
|FIRST INCIDENCE    |     733 (T)      ---          ---          ---         |---          ---          ---          628          |
|-------------------|                                                        |                                                    |
|STATISTICAL TESTS  |                                                        |                                                    |
|-------------------|                                                        |                                                    |
|LIFE TABLE         |     P=0.362N     P=0.484N     P=0.506N     P=0.506N    |P=0.037 *    (e)          (e)          P=0.214      |
|POLY 3             |     P=0.370N     P=0.491N     P=0.504N     P=0.498N    |P=0.037 *    (e)          (e)          P=0.220      |
|POLY 1.5           |     P=0.366N     P=0.493N     P=0.502N     P=0.500N    |P=0.039 *    (e)          (e)          P=0.225      |
|POLY 6             |     P=0.374N     P=0.488N     P=0.507N     P=0.497N    |P=0.036 *    (e)          (e)          P=0.215      |
|LOGISTIC REGRESSION|     P=0.362N     (e)          (e)          (e)         |P=0.042 *    (e)          (e)          P=0.239      |
|COCH-ARM / FISHERS |     P=0.356N     P=0.500N     P=0.500N     P=0.510N    |P=0.042 *    (e)          (e)          P=0.242      |
|=================================================================================================================================|
       Date:  03/09/99                           EXPERIMENT: 05180 TEST: 07                                            Page 16
                     Statistical Analysis of Primary Tumors in Mice(B6C3F1)       -                  GALLIUM ARSENIDE
                                         Terminal Sacrifice at 105 weeks 
|=================================================================================================================================|
|                   |                                                        |                                                    |
|                   |                              Males                     |                       Females                      |
|Dose               |     CONTROL      0.1          0.5          1.0         |CONTROL      0.1          0.5          1.0          |
|                   |                  MG/M3        MG/M3        MG/M3       |             MG/M3        MG/M3        MG/M3        |
|=================================================================================================================================|
|                                                                                                                                 |
|Thyroid Gland: Follicular Cell                                                                                                   |
|     Carcinoma or Adenoma                                                                                                        |
|                                                                                                                                 |
|                                                                                                                                 |
|---------------------------------------------------------------------------------------------------------------------------------|
|TUMOR RATES        |                                                        |                                                    |
|-----------        |                                                        |                                                    |
|OVERALL (a)        |     2/50 (4%)    1/50 (2%)    0/50 (0%)    0/48 (0%)   |1/50 (2%)    0/50 (0%)    0/50 (0%)    4/49 (8%)    |
|POLY-3 ADJUSTED (b)|     4.6%         2.2%         0.0%         0.0%        |2.2%         0.0%         0.0%         9.6%         |
|TERMINAL (d)       |     2/35 (6%)    1/38 (3%)    0/34 (0%)    0/34 (0%)   |1/36 (3%)    0/34 (0%)    0/31 (0%)    2/28 (7%)    |
|FIRST INCIDENCE    |     733 (T)      733 (T)      ---          ---         |735 (T)      ---          ---          628          |
|-------------------|                                                        |                                                    |
|STATISTICAL TESTS  |                                                        |                                                    |
|-------------------|                                                        |                                                    |
|LIFE TABLE         |     P=0.113N     P=0.471N     P=0.245N     P=0.245N    |P=0.014 *    P=0.511N     P=0.530N     P=0.129      |
|POLY 3             |     P=0.111N     P=0.484N     P=0.242N     P=0.235N    |P=0.016 *    P=0.498N     P=0.520N     P=0.156      |
|POLY 1.5           |     P=0.110N     P=0.488N     P=0.239N     P=0.238N    |P=0.018 *    P=0.500N     P=0.513N     P=0.163      |
|POLY 6             |     P=0.112N     P=0.479N     P=0.245N     P=0.233N    |P=0.015 *    P=0.497N     P=0.526N     P=0.149      |
|LOGISTIC REGRESSION|     P=0.113N     P=0.471N     (e)          (e)         |P=0.018 *    (e)          (e)          P=0.157      |
|COCH-ARM / FISHERS |     P=0.108N     P=0.500N     P=0.247N     P=0.258N    |P=0.021 *    P=0.500N     P=0.500N     P=0.175      |
|=================================================================================================================================|
|                   |                                                        |                                                    |
|                   |                              Males                     |                       Females                      |
|Dose               |     CONTROL      0.1          0.5          1.0         |CONTROL      0.1          0.5          1.0          |
|                   |                  MG/M3        MG/M3        MG/M3       |             MG/M3        MG/M3        MG/M3        |
|=================================================================================================================================|
|                                                                                                                                 |
|Uterus                                                                                                                           |
|     Polyp Stromal                                                                                                               |
|                                                                                                                                 |
|                                                                                                                                 |
|---------------------------------------------------------------------------------------------------------------------------------|
|TUMOR RATES        |     #            #            #            #           |#            #            #            #            |
|-----------        |                                                        |                                                    |
|OVERALL (a)        |                                                        |1/50 (2%)    2/50 (4%)    2/50 (4%)    2/50 (4%)    |
|POLY-3 ADJUSTED (b)|                                                        |2.2%         4.4%         4.9%         4.8%         |
|TERMINAL (d)       |                                                        |1/36 (3%)    2/34 (6%)    1/31 (3%)    2/29 (7%)    |
|FIRST INCIDENCE    |                                                        |735 (T)      735 (T)      560          735 (T)      |
|-------------------|                                                        |                                                    |
|STATISTICAL TESTS  |                                                        |                                                    |
|-------------------|                                                        |                                                    |
|LIFE TABLE         |                                                        |P=0.363      P=0.480      P=0.458      P=0.424      |
|POLY 3             |                                                        |P=0.406      P=0.504      P=0.470      P=0.478      |
|POLY 1.5           |                                                        |P=0.422      P=0.501      P=0.479      P=0.487      |
|POLY 6             |                                                        |P=0.389      P=0.506      P=0.463      P=0.467      |
|LOGISTIC REGRESSION|                                                        |P=0.416      P=0.480      P=0.505      P=0.424      |
|COCH-ARM / FISHERS |                                                        |P=0.442      P=0.500      P=0.500      P=0.500      |
|=================================================================================================================================|
       Date:  03/09/99                           EXPERIMENT: 05180 TEST: 07                                            Page 17
                     Statistical Analysis of Primary Tumors in Mice(B6C3F1)       -                  GALLIUM ARSENIDE
                                         Terminal Sacrifice at 105 weeks 
|=================================================================================================================================|
|                   |                                                        |                                                    |
|                   |                              Males                     |                       Females                      |
|Dose               |     CONTROL      0.1          0.5          1.0         |CONTROL      0.1          0.5          1.0          |
|                   |                  MG/M3        MG/M3        MG/M3       |             MG/M3        MG/M3        MG/M3        |
|=================================================================================================================================|
|                                                                                                                                 |
|Uterus                                                                                                                           |
|     Sarcoma Stromal or Polyp Stromal                                                                                            |
|                                                                                                                                 |
|                                                                                                                                 |
|---------------------------------------------------------------------------------------------------------------------------------|
|TUMOR RATES        |     #            #            #            #           |#            #            #            #            |
|-----------        |                                                        |                                                    |
|OVERALL (a)        |                                                        |1/50 (2%)    2/50 (4%)    3/50 (6%)    2/50 (4%)    |
|POLY-3 ADJUSTED (b)|                                                        |2.2%         4.4%         7.2%         4.8%         |
|TERMINAL (d)       |                                                        |1/36 (3%)    2/34 (6%)    1/31 (3%)    2/29 (7%)    |
|FIRST INCIDENCE    |                                                        |735 (T)      735 (T)      560          735 (T)      |
|-------------------|                                                        |                                                    |
|STATISTICAL TESTS  |                                                        |                                                    |
|-------------------|                                                        |                                                    |
|LIFE TABLE         |                                                        |P=0.332      P=0.480      P=0.266      P=0.424      |
|POLY 3             |                                                        |P=0.370      P=0.504      P=0.278      P=0.478      |
|POLY 1.5           |                                                        |P=0.387      P=0.501      P=0.286      P=0.487      |
|POLY 6             |                                                        |P=0.351      P=0.506      P=0.272      P=0.467      |
|LOGISTIC REGRESSION|                                                        |P=0.393      P=0.480      P=0.316      P=0.424      |
|COCH-ARM / FISHERS |                                                        |P=0.409      P=0.500      P=0.309      P=0.500      |
|=================================================================================================================================|
|                   |                                                        |                                                    |
|                   |                              Males                     |                       Females                      |
|Dose               |     CONTROL      0.1          0.5          1.0         |CONTROL      0.1          0.5          1.0          |
|                   |                  MG/M3        MG/M3        MG/M3       |             MG/M3        MG/M3        MG/M3        |
|=================================================================================================================================|
|                                                                                                                                 |
|All Organs                                                                                                                       |
|     Hemangioma                                                                                                                  |
|                                                                                                                                 |
|                                                                                                                                 |
|---------------------------------------------------------------------------------------------------------------------------------|
|TUMOR RATES        |     #            #            #            #           |#            #            #            #            |
|-----------        |                                                        |                                                    |
|OVERALL (a)        |     2/50 (4%)    1/50 (2%)    0/50 (0%)    0/50 (0%)   |0/50 (0%)    1/50 (2%)    2/50 (4%)    0/50 (0%)    |
|POLY-3 ADJUSTED (b)|     4.5%         2.2%         0.0%         0.0%        |0.0%         2.2%         4.9%         0.0%         |
|TERMINAL (d)       |     1/35 (3%)    1/38 (3%)    0/34 (0%)    0/34 (0%)   |0/36 (0%)    1/34 (3%)    2/31 (7%)    0/29 (0%)    |
|FIRST INCIDENCE    |     561          733 (T)      ---          ---         |---          735 (T)      735 (T)      ---          |
|-------------------|                                                        |                                                    |
|STATISTICAL TESTS  |                                                        |                                                    |
|-------------------|                                                        |                                                    |
|LIFE TABLE         |     P=0.112N     P=0.481N     P=0.248N     P=0.243N    |P=0.644N     P=0.489      P=0.206      (e)          |
|POLY 3             |     P=0.108N     P=0.489N     P=0.245N     P=0.234N    |P=0.613N     P=0.502      P=0.216      (e)          |
|POLY 1.5           |     P=0.107N     P=0.491N     P=0.241N     P=0.234N    |P=0.602N     P=0.500      P=0.223      (e)          |
|POLY 6             |     P=0.110N     P=0.486N     P=0.249N     P=0.236N    |P=0.625N     P=0.503      P=0.209      (e)          |
|LOGISTIC REGRESSION|     P=0.105N     P=0.518N     P=0.239N     P=0.255N    |(e)          P=0.489      P=0.206      (e)          |
|COCH-ARM / FISHERS |     P=0.105N     P=0.500N     P=0.247N     P=0.247N    |P=0.588N     P=0.500      P=0.247      (e)          |
|=================================================================================================================================|
       Date:  03/09/99                           EXPERIMENT: 05180 TEST: 07                                            Page 18
                     Statistical Analysis of Primary Tumors in Mice(B6C3F1)       -                  GALLIUM ARSENIDE
                                         Terminal Sacrifice at 105 weeks 
|=================================================================================================================================|
|                   |                                                        |                                                    |
|                   |                              Males                     |                       Females                      |
|Dose               |     CONTROL      0.1          0.5          1.0         |CONTROL      0.1          0.5          1.0          |
|                   |                  MG/M3        MG/M3        MG/M3       |             MG/M3        MG/M3        MG/M3        |
|=================================================================================================================================|
|                                                                                                                                 |
|All Organs                                                                                                                       |
|     Hemangiosarcoma                                                                                                             |
|                                                                                                                                 |
|                                                                                                                                 |
|---------------------------------------------------------------------------------------------------------------------------------|
|TUMOR RATES        |     #            #            #            #           |#            #            #            #            |
|-----------        |                                                        |                                                    |
|OVERALL (a)        |     3/50 (6%)    2/50 (4%)    6/50 (12%)   3/50 (6%)   |1/50 (2%)    2/50 (4%)    3/50 (6%)    0/50 (0%)    |
|POLY-3 ADJUSTED (b)|     6.7%         4.4%         13.6%        6.6%        |2.2%         4.4%         7.3%         0.0%         |
|TERMINAL (d)       |     1/35 (3%)    2/38 (5%)    2/34 (6%)    1/34 (3%)   |1/36 (3%)    1/34 (3%)    2/31 (7%)    0/29 (0%)    |
|FIRST INCIDENCE    |     570          733 (T)      502          599         |735 (T)      672          629          ---          |
|-------------------|                                                        |                                                    |
|STATISTICAL TESTS  |                                                        |                                                    |
|-------------------|                                                        |                                                    |
|LIFE TABLE         |     P=0.383      P=0.470N     P=0.236      P=0.658N    |P=0.382N     P=0.492      P=0.256      P=0.543N     |
|POLY 3             |     P=0.410      P=0.487N     P=0.236      P=0.651N    |P=0.351N     P=0.505      P=0.273      P=0.513N     |
|POLY 1.5           |     P=0.410      P=0.489N     P=0.240      P=0.652N    |P=0.336N     P=0.502      P=0.283      P=0.507N     |
|POLY 6             |     P=0.408      P=0.485N     P=0.232      P=0.651N    |P=0.368N     P=0.509      P=0.266      P=0.519N     |
|LOGISTIC REGRESSION|     P=0.394      P=0.506N     P=0.242      P=0.638     |P=0.335N     P=0.501      P=0.276      (e)          |
|COCH-ARM / FISHERS |     P=0.403      P=0.500N     P=0.243      P=0.661N    |P=0.318N     P=0.500      P=0.309      P=0.500N     |
|=================================================================================================================================|
|                   |                                                        |                                                    |
|                   |                              Males                     |                       Females                      |
|Dose               |     CONTROL      0.1          0.5          1.0         |CONTROL      0.1          0.5          1.0          |
|                   |                  MG/M3        MG/M3        MG/M3       |             MG/M3        MG/M3        MG/M3        |
|=================================================================================================================================|
|                                                                                                                                 |
|All Organs                                                                                                                       |
|     Hemangiosarcoma or Hemangioma                                                                                               |
|                                                                                                                                 |
|                                                                                                                                 |
|---------------------------------------------------------------------------------------------------------------------------------|
|TUMOR RATES        |     #            #            #            #           |#            #            #            #            |
|-----------        |                                                        |                                                    |
|OVERALL (a)        |     5/50 (10%)   3/50 (6%)    6/50 (12%)   3/50 (6%)   |1/50 (2%)    3/50 (6%)    5/50 (10%)   0/50 (0%)    |
|POLY-3 ADJUSTED (b)|     11.1%        6.5%         13.6%        6.6%        |2.2%         6.6%         12.2%        0.0%         |
|TERMINAL (d)       |     2/35 (6%)    3/38 (8%)    2/34 (6%)    1/34 (3%)   |1/36 (3%)    2/34 (6%)    4/31 (13%)   0/29 (0%)    |
|FIRST INCIDENCE    |     561          733 (T)      502          599         |735 (T)      672          629          ---          |
|-------------------|                                                        |                                                    |
|STATISTICAL TESTS  |                                                        |                                                    |
|-------------------|                                                        |                                                    |
|LIFE TABLE         |     P=0.465N     P=0.326N     P=0.478      P=0.362N    |P=0.400N     P=0.296      P=0.074      P=0.543N     |
|POLY 3             |     P=0.436N     P=0.347N     P=0.484      P=0.350N    |P=0.359N     P=0.311      P=0.081      P=0.513N     |
|POLY 1.5           |     P=0.433N     P=0.347N     P=0.493      P=0.348N    |P=0.339N     P=0.307      P=0.088      P=0.507N     |
|POLY 6             |     P=0.440N     P=0.348N     P=0.474      P=0.353N    |P=0.381N     P=0.314      P=0.077      P=0.519N     |
|LOGISTIC REGRESSION|     P=0.445N     P=0.370N     P=0.500      P=0.392N    |P=0.353N     P=0.308      P=0.080      (e)          |
|COCH-ARM / FISHERS |     P=0.436N     P=0.357N     P=0.500      P=0.357N    |P=0.317N     P=0.309      P=0.102      P=0.500N     |
|=================================================================================================================================|
       Date:  03/09/99                           EXPERIMENT: 05180 TEST: 07                                            Page 19
                     Statistical Analysis of Primary Tumors in Mice(B6C3F1)       -                  GALLIUM ARSENIDE
                                         Terminal Sacrifice at 105 weeks 
|=================================================================================================================================|
|                   |                                                        |                                                    |
|                   |                              Males                     |                       Females                      |
|Dose               |     CONTROL      0.1          0.5          1.0         |CONTROL      0.1          0.5          1.0          |
|                   |                  MG/M3        MG/M3        MG/M3       |             MG/M3        MG/M3        MG/M3        |
|=================================================================================================================================|
|                                                                                                                                 |
|All Organs                                                                                                                       |
|     Histiocytic Sarcoma                                                                                                         |
|                                                                                                                                 |
|                                                                                                                                 |
|---------------------------------------------------------------------------------------------------------------------------------|
|TUMOR RATES        |     #            #            #            #           |#            #            #            #            |
|-----------        |                                                        |                                                    |
|OVERALL (a)        |     3/50 (6%)    0/50 (0%)    0/50 (0%)    1/50 (2%)   |1/50 (2%)    0/50 (0%)    0/50 (0%)    0/50 (0%)    |
|POLY-3 ADJUSTED (b)|     6.8%         0.0%         0.0%         2.2%        |2.2%         0.0%         0.0%         0.0%         |
|TERMINAL (d)       |     2/35 (6%)    0/38 (0%)    0/34 (0%)    0/34 (0%)   |0/36 (0%)    0/34 (0%)    0/31 (0%)    0/29 (0%)    |
|FIRST INCIDENCE    |     647          ---          ---          716         |439          ---          ---          ---          |
|-------------------|                                                        |                                                    |
|STATISTICAL TESTS  |                                                        |                                                    |
|-------------------|                                                        |                                                    |
|LIFE TABLE         |     P=0.339N     P=0.111N     P=0.132N     P=0.306N    |P=0.356N     P=0.504N     P=0.517N     P=0.504N     |
|POLY 3             |     P=0.339N     P=0.112N     P=0.124N     P=0.298N    |P=0.356N     P=0.501N     P=0.523N     P=0.516N     |
|POLY 1.5           |     P=0.335N     P=0.114N     P=0.121N     P=0.298N    |P=0.354N     P=0.502N     P=0.516N     P=0.509N     |
|POLY 6             |     P=0.345N     P=0.110N     P=0.127N     P=0.300N    |P=0.358N     P=0.501N     P=0.530N     P=0.523N     |
|LOGISTIC REGRESSION|     P=0.326N     P=0.117N     P=0.122N     P=0.299N    |P=0.357N     P=0.427N     P=0.390N     P=0.543N     |
|COCH-ARM / FISHERS |     P=0.327N     P=0.121N     P=0.121N     P=0.309N    |P=0.351N     P=0.500N     P=0.500N     P=0.500N     |
|=================================================================================================================================|
|                   |                                                        |                                                    |
|                   |                              Males                     |                       Females                      |
|Dose               |     CONTROL      0.1          0.5          1.0         |CONTROL      0.1          0.5          1.0          |
|                   |                  MG/M3        MG/M3        MG/M3       |             MG/M3        MG/M3        MG/M3        |
|=================================================================================================================================|
|                                                                                                                                 |
|All Organs                                                                                                                       |
|     Malignant Lymphoma: Histiocytic, Lymphocytic, Mixed,                                                                        |
|     NOS, or Undifferentiated Cell Type                                                                                          |
|                                                                                                                                 |
|---------------------------------------------------------------------------------------------------------------------------------|
|TUMOR RATES        |     #            #            #            #           |#            #            #            #            |
|-----------        |                                                        |                                                    |
|OVERALL (a)        |     1/50 (2%)    1/50 (2%)    2/50 (4%)    1/50 (2%)   |3/50 (6%)    8/50 (16%)   11/50 (22%)  10/50 (20%)  |
|POLY-3 ADJUSTED (b)|     2.3%         2.2%         4.7%         2.2%        |6.6%         17.2%        26.6%        23.1%        |
|TERMINAL (d)       |     1/35 (3%)    1/38 (3%)    2/34 (6%)    1/34 (3%)   |1/36 (3%)    4/34 (12%)   9/31 (29%)   4/29 (14%)   |
|FIRST INCIDENCE    |     733 (T)      733 (T)      733 (T)      733 (T)     |639          533          581          595          |
|-------------------|                                                        |                                                    |
|STATISTICAL TESTS  |                                                        |                                                    |
|-------------------|                                                        |                                                    |
|LIFE TABLE         |     P=0.543      P=0.743N     P=0.490      P=0.755     |P=0.026 *    P=0.107      P=0.012 *    P=0.026 *    |
|POLY 3             |     P=0.571      P=0.751N     P=0.493      P=0.755N    |P=0.035 *    P=0.105      P=0.011 *    P=0.027 *    |
|POLY 1.5           |     P=0.572      P=0.753N     P=0.497      P=0.755N    |P=0.042 *    P=0.102      P=0.013 *    P=0.030 *    |
|POLY 6             |     P=0.567      P=0.747N     P=0.488      P=0.755N    |P=0.030 *    P=0.108      P=0.009 **   P=0.025 *    |
|LOGISTIC REGRESSION|     P=0.543      P=0.743N     P=0.490      P=0.755     |P=0.046 *    P=0.101      P=0.014 *    P=0.035 *    |
|COCH-ARM / FISHERS |     P=0.569      P=0.753N     P=0.500      P=0.753N    |P=0.056      P=0.100      P=0.020 *    P=0.036 *    |
|=================================================================================================================================|
       Date:  03/09/99                           EXPERIMENT: 05180 TEST: 07                                            Page 20
                     Statistical Analysis of Primary Tumors in Mice(B6C3F1)       -                  GALLIUM ARSENIDE
                                         Terminal Sacrifice at 105 weeks 
|=================================================================================================================================|
|                   |                                                        |                                                    |
|                   |                              Males                     |                       Females                      |
|Dose               |     CONTROL      0.1          0.5          1.0         |CONTROL      0.1          0.5          1.0          |
|                   |                  MG/M3        MG/M3        MG/M3       |             MG/M3        MG/M3        MG/M3        |
|=================================================================================================================================|
|                                                                                                                                 |
|All Organs                                                                                                                       |
|     Benign Tumors                                                                                                               |
|                                                                                                                                 |
|                                                                                                                                 |
|---------------------------------------------------------------------------------------------------------------------------------|
|TUMOR RATES        |     #            #            #            #           |#            #            #            #            |
|-----------        |                                                        |                                                    |
|OVERALL (a)        |     30/50 (60%)  28/50 (56%)  33/50 (66%)  28/50 (56%) |22/50 (44%)  24/50 (48%)  26/50 (52%)  22/50 (44%)  |
|POLY-3 ADJUSTED (b)|     64.5%        56.1%        71.0%        59.5%       |47.7%        52.4%        60.6%        49.7%        |
|TERMINAL (d)       |     24/35 (69%)  17/38 (45%)  24/34 (71%)  20/34 (59%) |16/36 (44%)  21/34 (62%)  19/31 (61%)  17/29 (59%)  |
|FIRST INCIDENCE    |     457          473          502          555         |617          659          483          505          |
|-------------------|                                                        |                                                    |
|STATISTICAL TESTS  |                                                        |                                                    |
|-------------------|                                                        |                                                    |
|LIFE TABLE         |     P=0.447      P=0.287N     P=0.302      P=0.462N    |P=0.210      P=0.351      P=0.118      P=0.273      |
|POLY 3             |     P=0.509      P=0.262N     P=0.323      P=0.386N    |P=0.461      P=0.404      P=0.154      P=0.510      |
|POLY 1.5           |     P=0.527N     P=0.306N     P=0.334      P=0.384N    |P=0.510      P=0.405      P=0.187      P=0.543      |
|POLY 6             |     P=0.461      P=0.212N     P=0.320      P=0.387N    |P=0.408      P=0.393      P=0.131      P=0.468      |
|LOGISTIC REGRESSION|     P=0.485N     P=0.423N     P=0.320      P=0.373N    |P=0.402      P=0.451      P=0.142      P=0.494      |
|COCH-ARM / FISHERS |     P=0.493N     P=0.420N     P=0.339      P=0.420N    |P=0.507N     P=0.421      P=0.274      P=0.580N     |
|=================================================================================================================================|
|                   |                                                        |                                                    |
|                   |                              Males                     |                       Females                      |
|Dose               |     CONTROL      0.1          0.5          1.0         |CONTROL      0.1          0.5          1.0          |
|                   |                  MG/M3        MG/M3        MG/M3       |             MG/M3        MG/M3        MG/M3        |
|=================================================================================================================================|
|                                                                                                                                 |
|All Organs                                                                                                                       |
|     Malignant Tumors                                                                                                            |
|                                                                                                                                 |
|                                                                                                                                 |
|---------------------------------------------------------------------------------------------------------------------------------|
|TUMOR RATES        |     #            #            #            #           |#            #            #            #            |
|-----------        |                                                        |                                                    |
|OVERALL (a)        |     23/50 (46%)  20/50 (40%)  26/50 (52%)  29/50 (58%) |26/50 (52%)  23/50 (46%)  26/50 (52%)  26/50 (52%)  |
|POLY-3 ADJUSTED (b)|     50.1%        41.3%        55.3%        59.0%       |53.8%        48.1%        56.9%        54.2%        |
|TERMINAL (d)       |     14/35 (40%)  13/38 (34%)  15/34 (44%)  16/34 (47%) |15/36 (42%)  12/34 (35%)  16/31 (52%)  8/29 (28%)   |
|FIRST INCIDENCE    |     561          478          393          406         |439          533          281          365          |
|-------------------|                                                        |                                                    |
|STATISTICAL TESTS  |                                                        |                                                    |
|-------------------|                                                        |                                                    |
|LIFE TABLE         |     P=0.061      P=0.259N     P=0.324      P=0.205     |P=0.183      P=0.402N     P=0.338      P=0.333      |
|POLY 3             |     P=0.073      P=0.258N     P=0.383      P=0.252     |P=0.380      P=0.362N     P=0.460      P=0.563      |
|POLY 1.5           |     P=0.066      P=0.278N     P=0.375      P=0.225     |P=0.403      P=0.365N     P=0.508      P=0.576      |
|POLY 6             |     P=0.081      P=0.243N     P=0.390      P=0.278     |P=0.357      P=0.358N     P=0.406      P=0.551      |
|LOGISTIC REGRESSION|     P=0.050      P=0.330N     P=0.339      P=0.162     |P=0.437      P=0.344N     P=0.555N     P=0.518N     |
|COCH-ARM / FISHERS |     P=0.051      P=0.343N     P=0.345      P=0.158     |P=0.408      P=0.345N     P=0.579N     P=0.579N     |
|=================================================================================================================================|
       Date:  03/09/99                           EXPERIMENT: 05180 TEST: 07                                            Page 21
                     Statistical Analysis of Primary Tumors in Mice(B6C3F1)       -                  GALLIUM ARSENIDE
                                         Terminal Sacrifice at 105 weeks 
|=================================================================================================================================|
|                   |                                                        |                                                    |
|                   |                              Males                     |                       Females                      |
|Dose               |     CONTROL      0.1          0.5          1.0         |CONTROL      0.1          0.5          1.0          |
|                   |                  MG/M3        MG/M3        MG/M3       |             MG/M3        MG/M3        MG/M3        |
|=================================================================================================================================|
|                                                                                                                                 |
|All Organs                                                                                                                       |
|     Malignant and Benign Tumors                                                                                                 |
|                                                                                                                                 |
|                                                                                                                                 |
|---------------------------------------------------------------------------------------------------------------------------------|
|TUMOR RATES        |     #            #            #            #           |#            #            #            #            |
|-----------        |                                                        |                                                    |
|OVERALL (a)        |     40/50 (80%)  37/50 (74%)  45/50 (90%)  41/50 (82%) |36/50 (72%)  36/50 (72%)  40/50 (80%)  39/50 (78%)  |
|POLY-3 ADJUSTED (b)|     83.9%        74.0%        91.8%        82.0%       |74.3%        75.1%        84.5%        80.3%        |
|TERMINAL (d)       |     28/35 (80%)  25/38 (66%)  30/34 (88%)  25/34 (74%) |24/36 (67%)  24/34 (71%)  26/31 (84%)  20/29 (69%)  |
|FIRST INCIDENCE    |     457          473          393          406         |439          533          281          365          |
|-------------------|                                                        |                                                    |
|STATISTICAL TESTS  |                                                        |                                                    |
|-------------------|                                                        |                                                    |
|LIFE TABLE         |     P=0.196      P=0.205N     P=0.194      P=0.476     |P=0.047 *    P=0.498      P=0.092      P=0.110      |
|POLY 3             |     P=0.300      P=0.171N     P=0.186      P=0.510N    |P=0.202      P=0.555      P=0.158      P=0.320      |
|POLY 1.5           |     P=0.277      P=0.200N     P=0.165      P=0.554N    |P=0.218      P=0.552      P=0.185      P=0.330      |
|POLY 6             |     P=0.323      P=0.149N     P=0.216      P=0.470N    |P=0.185      P=0.560      P=0.131      P=0.311      |
|LOGISTIC REGRESSION|     P=0.211      P=0.288N     P=0.123      P=0.535     |P=0.176      P=0.587      P=0.192      P=0.315      |
|COCH-ARM / FISHERS |     P=0.209      P=0.318N     P=0.131      P=0.500     |P=0.208      P=0.588N     P=0.241      P=0.322      |
|=================================================================================================================================|

(a)  Number of tumor-bearing animals /  number of animals examined at site.
(b)  Poly-3 adjusted lifetime tumor incidence.
(d)  Observed incidence at terminal kill.
(f)  Beneath the control incidence are the P-values associated with the trend 
test.  Beneath the dosed group incidence are the P-values corresponding to 
pairwise comparisons between the controls and that dosed group.  The life
table analysis regards tumors in animals dying prior to  terminal kill as
 being (directly or indirectly) the cause of death.
Logistic regression is an alternative
 method for analyzing the incidence of non-fatal tumors. The Cochran-Armitage
and Fishers exact tests compare directly the overall incidence rates
For all tests a negative trend is indicated by N
(e)  Value of Statistic cannot be computed.
(I)  Interim sacrifice
(T)  Terminal sacrifice
#   Tumor rates based on number of animals necropsied.
*   To the right of any statistical result, indicates significance at (P<=0.05).
**  To the right of any statistical result, indicates significance at (P<=0.01).